{"study_id": 21820, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the effects of Lactobacillus casei on various stages of biofilm formation in Gardnerella species and its potential role in treating bacterial vaginosis.", "results_summary": "Lactobacillus casei Xbb-LC-1 inhibited Gardnerella species biofilm formation, particularly when added at the initial stage. Maintaining an acidic vaginal environment (pH <4.5) with Lactobacillus dominance significantly prevented biofilm formation.", "population_specificity": "Gardnerella species, including Gardnerella vaginalis ATCC 14018 and six clinically isolated strains.", "effective_dosage": "Not specified", "study_duration": "24 hours (co-culture period)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:59.133236+00:00"}
{"study_id": 21822, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to investigate the efficacy of heat-killed Lactobacillus casei DKGF7 in improving irritable bowel syndrome (IBS) symptoms in a rat model and to explore its underlying mechanisms.", "results_summary": "The treatment group showed significantly better stool consistency, lower serum corticosterone levels, reduced colonic inflammatory cytokines, and higher expression of tight junction proteins compared to the control group. These findings suggest heat-killed L. casei DKGF7 may be a potential therapeutic strategy for IBS.", "population_specificity": "Male Wistar rats with induced IBS via restraint stress.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:59.756935+00:00"}
{"study_id": 21827, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the tumor-inhibiting effects of combining Lactobacillus casei TD2a with GM-CSF on HPV-associated tumors in mice.", "results_summary": "The combination of L. casei and GM-CSF significantly enhanced tumor inhibition, immune responses (cytolytic and splenocyte proliferation), and cytokine levels (IFN-\u03b3, IL-4, IL-12) while reducing IL-10 accumulation in the tumor microenvironment. The combined treatment also increased intratumoral TRAIL and suppressed tumor growth more effectively than individual treatments.", "population_specificity": "Transplanted mice with TC-1 tumors (HPV-associated tumor model).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:59.758285+00:00"}
{"study_id": 21825, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "To evaluate the efficacy of Lactobacillus paracasei CNCM I-1572 in preventing symptomatic recurrences and improving quality of life in patients with chronic bacterial prostatitis.", "results_summary": "The study found that 72.6% of patients reported clinical improvement, with significant reductions in symptom scores and antibiotic use, and no clinically relevant adverse effects were reported.", "population_specificity": "Patients with chronic bacterial prostatitis attending a single urological institution.", "effective_dosage": "2 capsules/day", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:59.776409+00:00"}
{"study_id": 21826, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 78, "quality_score": 72, "study_goal": "The researchers aimed to evaluate the antioxidant and immunomodulatory activities of exopolysaccharides (EPS) from Lactobacillus casei NA-2 in vitro.", "results_summary": "EPS demonstrated antioxidant activity by scavenging radicals and showed immunomodulatory effects by promoting ROS and TNF-\u03b1 production in unstimulated macrophages while reducing NO and iNOS levels in LPS-induced macrophages. The study suggests EPS has potential anti-inflammatory and protective effects against oxidative damage.", "population_specificity": "RAW 264.7 macrophages (in vitro study)", "effective_dosage": "31.25 to 500 \u00b5g/mL", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:00.559147+00:00"}
{"study_id": 21828, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lactobacillus casei improves fermentation quality and microbial community dynamics in alfalfa silage compared to untreated or cellulase-treated silage.", "results_summary": "Lactobacillus casei significantly improved silage quality by lowering pH, increasing lactic acid content, and promoting Lactobacillus dominance in bacterial communities. The treatment also preserved leaf epicuticular wax structure better than untreated silage.", "population_specificity": "Alfalfa silage (first cutting, 29% dry matter).", "effective_dosage": "1 \u00d7 10^6 cfu g^-1 fresh matter.", "study_duration": "56 days of ensiling followed by 3 days of air exposure.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:06.509135+00:00"}
{"study_id": 21829, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effects of Lactobacillus casei against carbon tetrachloride (CCl4)-induced reproductive injury and sperm toxicity in rats.", "results_summary": "Lactobacillus casei improved reproductive hormone levels, antioxidant capacity, and spermatogenesis rates while down-regulating pro-apoptotic genes (Bax) and up-regulating anti-apoptotic genes (Bcl-2). It also enhanced testicular histomorphometric indices and sperm parameters.", "population_specificity": "Wistar rats (32 animals divided into four groups).", "effective_dosage": "Not specified (probiotic administered alongside 2 ml/kg CCl4).", "study_duration": "36 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:07.040340+00:00"}
{"study_id": 21830, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the mechanisms by which fermented milk containing Lactobacillus casei Zhang and Bifidobacterium animalis ssp. lactis V9 alleviates constipation symptoms.", "results_summary": "The study found significant improvement in constipation symptoms, increased anti-inflammatory cytokine IL-10, decreased proinflammatory markers, and altered metabolic pathways related to fatty acid and bile acid biosynthesis. The increase in B. animalis correlated with higher defecation frequency, and acylcarnitine positively influenced defecation.", "population_specificity": "Volunteers with chronic constipation symptoms", "effective_dosage": "200 g/d of fermented milk", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:07.498016+00:00"}
{"study_id": 21832, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of Lactobacillus casei ZX633 on gut microbiota composition in infants with diarrhea, comparing it to healthy infants.", "results_summary": "L. casei ZX633 increased certain beneficial bacteria (E. coli, yeasts, LAB) and propionic acid while reducing other SCFAs, shifting microbial structure toward that of healthy infants. However, microbial diversity and richness decreased in the treatment group.", "population_specificity": "Infants with diarrhea (treatment group) and healthy infants (control group).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:08.173587+00:00"}
{"study_id": 21833, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the prophylactic effects of five Lactobacillus casei strains on house dust mite (HDM)-induced asthma in mice.", "results_summary": "All five L. casei strains reduced granulocytes and Th2/Th17 inflammatory cytokines, with L. casei3 showing the most significant reduction in airway inflammation. Some strains also modulated immunoglobulin levels and gut microbiota composition, with L. casei3 exhibiting the highest prophylactic effect.", "population_specificity": "BALB/c mice", "effective_dosage": "Not specified", "study_duration": "One week before HDM treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:08.727489+00:00"}
{"study_id": 21831, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether milk fermented by Lactobacillus casei CRL431 (PFM) could reduce the side effects of capecitabine while maintaining its anti-tumor and anti-metastatic effects in breast cancer models.", "results_summary": "PFM reduced capecitabine side effects, improved immune response, and maintained anti-cancer/anti-metastasis effects in mouse models. It also independently reduced metastasis without side effects.", "population_specificity": "BALB/c mice (healthy, bearing breast cancer, or with potential metastasis).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Capecitabine (chemotherapy drug).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:09.332285+00:00"}
{"study_id": 21834, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether Lactobacillus casei strain T2 could alleviate demyelination symptoms and modulate inflammatory markers in a cuprizone-induced mouse model of multiple sclerosis.", "results_summary": "The study found that Lactobacillus casei significantly reduced miR-155 expression and IL-17 levels in treated mice, suggesting it may reduce proinflammatory cytokines and demyelinating symptoms. The effects were observed across multiple treatment regimens, including combinations with vitamin D3.", "population_specificity": "Female C57BL/6 mice (8-10 weeks old)", "effective_dosage": "1 \u00d7 10^9 CFU/ml probiotic (oral administration)", "study_duration": "4 weeks (for probiotic administration in each treatment group)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:09.795701+00:00"}
{"study_id": 71950, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to systematically review randomized clinical studies investigating the effect of probiotics, including Lactobacillus Casei, on managing osteoarthritis-related pain and inflammation.", "results_summary": "The study found a significant reduction in OA-related symptoms, including pain and impediment, but not stiffness, across the analyzed outcomes. Serum hs-CRP levels also showed improvement.", "population_specificity": "501 participants with osteoarthritis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:14.141756+00:00"}
{"study_id": 71953, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the potential role of gut microbiota in rheumatoid arthritis (RA) and explore the feasibility of using Lactobacillus casei as a supplementary treatment for RA.", "results_summary": "The study suggests that Lactobacillus casei, a probiotic with immunomodulatory properties, has beneficial effects for RA in both murine and human models, contrasting with higher quantities of other bacteria found in RA patients.", "population_specificity": "Murine and human models (specific details not provided).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:15.497605+00:00"}
{"study_id": 21835, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether a DFM product containing Lactobacillus Casei and Lactobacillus acidophilus could reduce fecal shedding of E. coli O157:H7 in feedlot cattle.", "results_summary": "The study found no significant reduction in E. coli O157:H7 fecal prevalence or supershedding prevalence in cattle treated with the DFM product compared to controls. The results were consistent across both feedlots, with only one instance of a marginally significant effect (p=0.04) for supershedding in Nebraska.", "population_specificity": "Finishing commercial feedlot cattle in Kansas and Nebraska.", "effective_dosage": "1 \u00d7 10^9 CFU per animal daily (combination of Lactobacillus acidophilus and Lactobacillus casei).", "study_duration": "At least 60 days before sampling.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:16.024691+00:00"}
{"study_id": 71955, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the therapeutic potential of Lactobacillus casei Shirota in managing symptoms of obsessive-compulsive disorder (OCD) through gut microbiota modulation.", "results_summary": "The study found that Lactobacillus casei Shirota, among other probiotics, imparted positive effects in managing OCD symptoms by influencing the microbiota-gut-brain axis, neurotransmitter activity, and inflammatory pathways.", "population_specificity": "Individuals with obsessive-compulsive disorder (OCD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:16.751319+00:00"}
{"study_id": 71951, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the role of Lactobacillus casei Zhang, in combination with other probiotics and atorvastatin, in treating hyperlipidemia by optimizing gut microbiota and reducing harmful bacteria.", "results_summary": "Probiotics, including Lactobacillus casei, improved gut microbial abundance and diversity, increased beneficial bacteria (e.g., Bifidobacterium, Lactobacillus), and reduced harmful bacteria (e.g., Escherichia). They also contributed to significant reductions in total cholesterol, triglycerides, and LDL-C levels.", "population_specificity": "33 patients with hyperlipidemia (18 in probiotic group, 15 in control group).", "effective_dosage": "2 g once daily (probiotic blend) + atorvastatin 20 mg once daily.", "study_duration": "3 months.", "interactions": "Combined with atorvastatin (no adverse interactions mentioned).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:17.259150+00:00"}
{"study_id": 71954, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of 3-month supplementation with oral probiotics (including Lactobacillus Casei) on quality of life and inflammatory markers in women with primary dysmenorrhea.", "results_summary": "The probiotic group showed improved mental health scores and potentially reduced nonsteroidal anti-inflammatory drug use, but there was no significant difference in quality of life scores or inflammatory markers compared to the placebo group.", "population_specificity": "Women with primary dysmenorrhea (72 patients, 36 in each arm).", "effective_dosage": "5 billion colony-forming units per sachet (frequency not specified).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:17.372603+00:00"}
{"study_id": 71956, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effectiveness of biotics, including Lactobacillus casei, in reducing the occurrence and severity of oral mucositis in cancer patients.", "results_summary": "The study found that Lactobacillus casei, along with other probiotics, reduced the occurrence of oral mucositis in clinical studies and decreased its severity in pre-clinical studies. However, the evidence was marked by significant heterogeneity across studies.", "population_specificity": "Patients undergoing cancer treatment (specific cancer types not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:19.467438+00:00"}
{"study_id": 71957, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the microbial contamination of removable orthodontic appliances and the efficacy of chlorhexidine gluconate spray in reducing cariogenic microorganisms, including Lactobacillus casei.", "results_summary": "Lactobacillus casei was found in lower abundance compared to other cariogenic microorganisms like Streptococcus mutans and Streptococcus sobrinus. The use of chlorhexidine spray significantly reduced the number of Lactobacillus casei (P <0.05).", "population_specificity": "Children aged 7-11 years wearing removable orthodontic appliances.", "effective_dosage": "0.12% chlorhexidine gluconate spray applied twice a week (days 4 and 7).", "study_duration": "1 week.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:23.229481+00:00"}
{"study_id": 71962, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of Lactobacillus Casei Shirota on stool frequency, consistency, and integrative symptom scores in adults with chronic constipation.", "results_summary": "The study found that Lactobacillus Casei Shirota did not significantly increase stool frequency or impact stool consistency compared to control, though probiotics overall showed some benefits for integrative symptom scores.", "population_specificity": "Adults with chronic constipation", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:24.565919+00:00"}
{"study_id": 71958, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of manual and interactive power toothbrushes on salivary levels of Lactobacillus casei in orthodontic patients.", "results_summary": "The study found no significant difference in salivary L. casei levels between the manual and interactive power toothbrush groups at any time point (T0, T1, T2). The results suggest that brush type did not influence L. casei concentrations.", "population_specificity": "40 orthodontic patients (20 females, 20 males; aged 12-18 years) with fixed orthodontic appliances.", "effective_dosage": "Not specified (study focused on toothbrush type, not L. casei dosage).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:25.212732+00:00"}
{"study_id": 71963, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of two probiotic formulations, including Lactobacillus casei, in improving symptoms of functional constipation in adults.", "results_summary": "The study found that both probiotic formulations, including Lactobacillus casei, improved stool frequency and quality in adults with functional constipation, with no significant differences between groups. Only one mild adverse event (abdominal pain) was reported.", "population_specificity": "Adults with functional constipation.", "effective_dosage": "8 billion CFU (including Lactobacillus casei) administered once daily.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:25.447066+00:00"}
{"study_id": 71961, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the clinical efficacy of a probiotic mixture containing Lactobacillus Casei in improving atopic dermatitis symptoms and reducing corticosteroid use in pediatric patients.", "results_summary": "The probiotic mixture significantly improved SCORAD and IGA scores compared to placebo and reduced corticosteroid use between weeks 6-12, though no significant difference was observed in total corticosteroid dose over the entire study period. Adverse events were similar between groups.", "population_specificity": "Children and adolescents aged 4-17 years with atopic dermatitis.", "effective_dosage": "1 \u00d7 10^9 colony-forming units per capsule daily (combined with Bifidobacterium lactis and Bifidobacterium longum).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:26.466626+00:00"}
{"study_id": 21823, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective function of surface layer protein (SLP) from Lactobacillus casei fb05 against the harmful effects of E. coli and Salmonella on intestinal tissue.", "results_summary": "The study found that L. casei fb05 SLP reduced pathogen adhesion to collagen and HT-29 cells by 45%-49% and inhibited pathogen-induced apoptosis by decreasing caspase-9 and caspase-3 activation.", "population_specificity": "In vitro study using HT-29 cells (human intestinal epithelial cell line) and collagen.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:27.472876+00:00"}
{"study_id": 71964, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the efficacy and safety of synbiotic supplementation (including Lactobacillus casei) in reducing gut-derived uremic toxins and inflammation in chronic kidney disease patients.", "results_summary": "Synbiotic treatment enriched beneficial gut bacteria (including Lactobacillus), significantly reduced serum indoxyl sulfate, improved kidney function (eGFR), and decreased inflammation (hs-CRP), with only minor adverse effects (increased flatulence in two patients).", "population_specificity": "34 nondialyzed chronic kidney disease patients (aged \u226518, eGFR 15\u201345 mL/minute).", "effective_dosage": "32 billion CFU/day (combined with Lactobacillus acidophilus, Bifidobacterium lactis, and 3.2 g inulin).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:28.693502+00:00"}
{"study_id": 71970, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specify the researchers' goals regarding Lactobacillus Casei.", "results_summary": "The abstract does not provide results related to Lactobacillus Casei.", "population_specificity": "Not specified in the provided abstract.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:31.357920+00:00"}
{"study_id": 71966, "supplement_id": 1274, "safety_score": "75", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to assess whether Lactobacillus casei, when added to standard Helicobacter pylori eradication therapy in children, improves eradication rates and reduces adverse effects.", "results_summary": "The study found low-quality evidence that Lactobacillus casei increases the eradication rate of H. pylori and decreases adverse effects, though the evidence is limited due to study heterogeneity and only one randomized controlled trial. Synbiotics showed only a trend toward better eradication.", "population_specificity": "Children undergoing Helicobacter pylori eradication therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:32.000340+00:00"}
{"study_id": 71965, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of a multistrain probiotic mixture, including Lactobacillus casei BGP93, in improving functional constipation and blood parameters in elderly nursing home residents.", "results_summary": "The probiotic mixture, including Lactobacillus casei, showed a significant increase in stool frequency after 71 days when laxative use was excluded, indicating a prolonged effect. No significant adverse effects or changes in blood parameters were observed.", "population_specificity": "Elderly nursing home residents (60 participants, aged 77.9 \u00b1 8.84 years, with functional constipation).", "effective_dosage": "Not specified (liquid formulation containing Bifidobacterium animalis subsp. lactis BLC1, Lactobacillus acidophilus LA3, and Lactobacillus casei BGP93).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:32.277158+00:00"}
{"study_id": 71969, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine the influence of fermented soymilk-honey made with different probiotics, including Lactobacillus Casei, on osteocalcin levels in postmenopausal women.", "results_summary": "The abstract does not provide specific results regarding Lactobacillus Casei's effects on osteocalcin levels, only stating that the study aimed to investigate this relationship.", "population_specificity": "54 postmenopausal women divided into three intervention groups.", "effective_dosage": "Not available", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:33.135550+00:00"}
{"study_id": 71959, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of Lactobacillus casei oral supplementation on episiotomy wound healing in primiparous women.", "results_summary": "The study found that Lactobacillus casei significantly improved wound healing compared to placebo, with lower wound healing scores (indicating better healing) at 5 and 15 days postpartum in the probiotic group. The adjusted mean difference was statistically significant (P=0.03).", "population_specificity": "Primiparous women with mediolateral episiotomy (incision length \u22645 cm) in Iran.", "effective_dosage": "1.5 * 10^9 CFU of Lactobacillus casei 431 (frequency not specified).", "study_duration": "Intervention duration not explicitly stated, but outcomes were measured at 5\u00b11 and 15\u00b11 days postpartum.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:34.834377+00:00"}
{"study_id": 71973, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the substrate specificity and activity of the bacterial \u03b1-l-fucosidase AlfC from Lactobacillus casei with other fucosidases, particularly its ability to remove core fucose from glycoproteins.", "results_summary": "The study found that AlfC from Lactobacillus casei could not remove core fucose from intact full-length N-glycopeptides or N-glycoproteins but could hydrolyze only truncated Fuc\u03b11,6GlcNAc-peptide substrates, showing limited efficacy compared to human \u03b1-l-fucosidase (FucA1).", "population_specificity": "Not applicable (in vitro study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:35.046093+00:00"}
{"study_id": 71975, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of probiotic Lactobacillus strains, including Lactobacillus Casei, as an alternative therapy for allergic rhinitis and asthma by reviewing current studies.", "results_summary": "The study found that Lactobacillus species, including Lactobacillus Casei, provided symptom relief and improved quality of life in allergic rhinitis patients, with changes in cytokine profiles and reduced allergy-related immunoglobulins. However, the exact mechanism of immune modulation remains unclear.", "population_specificity": "Children and adults suffering from allergic rhinitis or asthma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:35.186319+00:00"}
{"study_id": 71977, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential role of Lactobacillus casei in enhancing anti-coronavirus vaccine efficacy and its benefits for diabetes.", "results_summary": "The study suggested that Lactobacillus casei, along with other probiotics, could serve as vectors for delivering or enhancing anti-coronavirus vaccines and may be beneficial for diabetes, though no direct proof of benefits for COVID-19 infection was provided.", "population_specificity": "Patients with diabetes and potential COVID-19 infection.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:36.012538+00:00"}
{"study_id": 71980, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of a probiotic product containing Lactobacillus casei Zhang as an adjunct to a routine regimen in managing irritable bowel syndrome (IBS).", "results_summary": "The probiotic group showed significant reductions in IBS symptom severity, serum inflammatory markers (IL-6, TNF-\u03b1), and harmful bacterial genera, though some beneficial genera also decreased. Clinical improvement was linked to gut microbiota modulation, and initial microbiome composition influenced outcomes.", "population_specificity": "45 patients with irritable bowel syndrome (IBS).", "effective_dosage": "Not specified", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:39.782746+00:00"}
{"study_id": 71979, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of a probiotic mixture containing Lactobacillus casei (TMC) in improving lipid profiles and intestinal function in mild hypercholesterolemic volunteers.", "results_summary": "The probiotic mixture significantly improved fecal weight, gastrointestinal transit time, and beneficial gut microbiota while reducing total cholesterol (8.1%) and LDL-c (10.4%). It also increased the lag time of LDL oxidation, indicating cardioprotective effects.", "population_specificity": "40 healthy mild hypercholesterolemic subjects (180-220 mg/dL).", "effective_dosage": "30 g of probiotic-contained milk formula mixed with 200 mL of water, daily.", "study_duration": "10 weeks of intervention followed by 2 weeks of follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:40.094068+00:00"}
{"study_id": 71982, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the potential of genetically modified lactic acid bacteria (LAB), including Lactobacillus Casei, as mucosal HPV vaccines to induce immune responses against HPV-associated cervical cancer.", "results_summary": "The study found that LAB-based HPV vaccines, particularly those expressing surface-anchored antigens, show promise in inducing systemic and mucosal cytotoxic immune responses. The review highlights key factors for improving protein yield and immune response in therapeutic HPV vaccine development.", "population_specificity": "Not specified (review of international studies from 2000-2020)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:40.327069+00:00"}
{"study_id": 71981, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of fermented milk containing Lactobacillus casei strain Shirota (LcS) on the incidence of constipation, diarrhea, acute respiratory infections (ARI), and nutritional status in young Vietnamese children.", "results_summary": "The probiotic drink significantly reduced the incidence of constipation and ARI, showed a trend toward reducing diarrhea, and improved weight gain compared to the control group. No effects were observed on the duration of diarrhea or ARI.", "population_specificity": "1003 Vietnamese children aged 3-5 years in Thanh Hoa province.", "effective_dosage": "65 mL/day containing 10^8 CFU/mL of LcS.", "study_duration": "12-week intervention with a 4-week follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:41.513471+00:00"}
{"study_id": 71985, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to examine the potential health maintenance benefits of long-term lactic acid bacteria-based probiotics, specifically in relation to weight loss in the elderly.", "results_summary": "The abstract does not provide specific results regarding Lactobacillus Casei's effects, only mentioning the study's observational nature and its focus on health maintenance.", "population_specificity": "Elderly participants from a previous clinical study.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:41.855479+00:00"}
{"study_id": 71983, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to investigate the treatment efficacy of Lactobacillus Casei for vestibular migraine (VM).", "results_summary": "The abstract does not provide specific results regarding Lactobacillus Casei's effects on VM, only stating that its effect on VM is not clear.", "population_specificity": "Patients with vestibular migraine (VM).", "effective_dosage": "Not provided", "study_duration": "Not provided", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:41.951828+00:00"}
{"study_id": 71984, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the comparative effectiveness of different probiotic strains, including Lactobacillus casei, in treating pediatric atopic dermatitis.", "results_summary": "Lactobacillus casei DN-114001 showed potential in reducing atopic dermatitis symptoms based on low certainty evidence (SMD -1.35). Another mix containing Lactobacillus casei (Mix6) demonstrated moderate efficacy (SMD -0.85).", "population_specificity": "Pediatric patients with atopic dermatitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:42.384969+00:00"}
{"study_id": 71986, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to compare the effects of low- and high-dose multi-strain probiotic supplements containing Lactobacillus Casei in the general adult population.", "results_summary": "The abstract does not provide specific results regarding Lactobacillus Casei's effects, only stating the study's aim to compare dosage responses.", "population_specificity": "General adult population", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:43.463422+00:00"}
{"study_id": 71987, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Lactobacillus casei cell wall extract (LCWE) in studying Kawasaki disease (KD) pathophysiology and advancing treatment strategies.", "results_summary": "The study found that LCWE-induced KD vasculitis in a mouse model accelerated research into KD pathophysiology and supported clinical trials for IL-1R antagonist (Anakinra) as a treatment. LCWE contributed to understanding novel genetic risk factors and combination therapies for refractory KD.", "population_specificity": "Mouse model (not human subjects)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:47.587096+00:00"}
{"study_id": 71990, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review recent literature on the efficacy of probiotics, including Lactobacillus Casei, against pathogens causing wound infections.", "results_summary": "The study found that probiotics can aid in skin healing by stimulating immune cell production and exhibit antagonistic effects against pathogens through competitive exclusion. Fourteen studies were reviewed, supporting these mechanisms.", "population_specificity": "Not specified (literature review of existing studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:47.808795+00:00"}
{"study_id": 71988, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were investigating the role of IL-1 signaling in sex-based differences in Kawasaki disease (KD) susceptibility, not Lactobacillus Casei.", "results_summary": "The study found that IL-1\u03b2 may mediate sex-based differences in KD, suggesting implications for anti-IL-1\u03b2 therapies, but did not examine Lactobacillus Casei.", "population_specificity": "Children with Kawasaki disease (KD)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:47.981100+00:00"}
{"study_id": 71991, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to determine the effectiveness of Lactobacillus casei in preventing Clostridium difficile-associated diarrhea (CDAD) and antibiotic-associated diarrhea (AAD) compared to other probiotics and placebo.", "results_summary": "Lactobacillus casei was the most effective probiotic intervention, significantly reducing the incidence rates of CDAD (OR 0.19) and AAD (OR 0.32) compared to placebo. It also ranked highest in reducing diarrhea duration and delaying onset.", "population_specificity": "4,692 patients from randomized controlled trials (RCTs) evaluating probiotic interventions for CDAD and AAD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:49.419266+00:00"}
{"study_id": 71994, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 25, "quality_score": 75, "study_goal": "The researchers aimed to determine whether daily oral Lactobacillus casei Shirota (LcS) could improve CD4+ T-cell counts, CD4+/CD8+ ratio, immune activation, and intestinal microbiome composition in HIV-infected patients on suppressive ART with poor CD4+ recovery.", "results_summary": "The study found no statistically significant effect of LcS on CD4+ T-cell counts, CD4+/CD8+ ratio, immune activation markers, or intestinal microbiome composition at 6 or 12 weeks compared to placebo.", "population_specificity": "HIV-infected patients on suppressive ART with poor CD4+ recovery.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:50.801843+00:00"}
{"study_id": 71993, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of synbiotic supplementation (including Lactobacillus casei) on anthropometric indices, metabolic markers, and psychological status in adults with overweight or obesity.", "results_summary": "The study found that synbiotic supplementation significantly improved body weight, total cholesterol, triglycerides, LDL-C, stress, anxiety, and depression, but had no significant effect on HDL-C, blood pressure, fasting glucose, insulin, BMI, or waist circumference.", "population_specificity": "Adults with overweight or obesity (39 men and 20 women).", "effective_dosage": "500 mg capsule (containing Lactobacillus casei, Lactobacillus acidophilus, Bifidobacterium bifidum, and inulin) daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:50.883326+00:00"}
{"study_id": 71992, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether daily consumption of Lactobacillus casei could prevent gastrointestinal adverse events caused by anti-tuberculosis (TB) drugs.", "results_summary": "Both high and low doses of L. casei reduced the incidence and duration of anti-TB-associated gastrointestinal adverse events compared to the control group, with higher doses showing better effects for vomiting and appetite loss.", "population_specificity": "429 adult patients undergoing intensive-phase anti-TB therapy.", "effective_dosage": "One bottle (10 billion CFU) per day (low-dose) or two bottles (20 billion CFU) per day (high-dose).", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:51.911321+00:00"}
{"study_id": 71995, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of BLS-M07 (containing Lactobacillus Casei expressing HPV16 E7 antigen) as a non-surgical treatment for CIN 3 by assessing immune response and pathological regression.", "results_summary": "BLS-M07 demonstrated safety with no severe adverse events, improved RCI grading, and increased HPV16 E7 antibody production. In phase 2a, 75% of CIN 3 patients were cured.", "population_specificity": "Patients with CIN 3 (cervical intraepithelial neoplasia grade 3).", "effective_dosage": "500 mg, 1,000 mg, and 1,500 mg administered orally 5 times a week on weeks 1, 2, 4, and 8 (phase 1); 1,000 mg in phase 2a.", "study_duration": "16 weeks (follow-up after treatment).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:53.310120+00:00"}
{"study_id": 71996, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether oral Lactobacillus casei Shirota (LcS) administration could accelerate hand function recovery in senior patients with acute distal radius fractures.", "results_summary": "The study found that patients receiving LcS showed significantly faster improvement in Michigan Hand Questionnaire scores, radial deviation and inclination, and ulnar deviation and variance compared to the placebo group over the 3-month intervention period.", "population_specificity": "Senior patients diagnosed with acute distal radius fractures.", "effective_dosage": "Daily administration (specific dosage not mentioned).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:54.934962+00:00"}
{"study_id": 71997, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the influence of ora-pro-nobis flour on the adhesion of Lactobacillus casei to intestinal epithelial cells and its effects on gastrointestinal symptoms and metabolic parameters in overweight men.", "results_summary": "The study found that ora-pro-nobis flour did not affect Lactobacillus casei adhesion to Caco-2 cells but improved gastrointestinal symptoms and satiety while maintaining high adherence of L. casei to intestinal cells and stable anthropometric and biochemical parameters.", "population_specificity": "Overweight men", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:55.878878+00:00"}
{"study_id": 71998, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the safety and efficacy of a probiotic mixture containing Lactobacillus casei in reducing pro-inflammatory cytokines in colorectal cancer patients post-surgery.", "results_summary": "The study found that the probiotic mixture significantly reduced pro-inflammatory cytokines (TNF-\u03b1, IL-6, IL-10, IL-12, IL-17A, IL-17C, IL-22) in colorectal cancer patients, with no significant difference in IFN-\u03b3 levels. No surgical infections or antibiotic requirements were reported.", "population_specificity": "Fifty-two colorectal cancer patients, four weeks post-surgery, with ~70% in Duke's C stage.", "effective_dosage": "30 billion CFU of a six-strain mixture, taken orally twice daily.", "study_duration": "Six months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:56.666062+00:00"}
{"study_id": 71999, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether probiotic supplementation, including Lactobacillus Casei, modulates gut microbiota and its association with obesity and cardiometabolic risk factors.", "results_summary": "The probiotic mixture influenced gut microbiota composition, reducing TM7 (associated with adiposity) and increasing Clostridiaceae (linked to lower TNF-\u03b1). TM7 was more prevalent in subjects with higher adiposity, suggesting its role as a potential target for obesity treatment.", "population_specificity": "Subjects with obesity and cardiometabolic risk factors (specific demographics not detailed).", "effective_dosage": "2 \u00d7 10^? CFU (exact dosage unclear from abstract).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:57.403599+00:00"}
{"study_id": 72001, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effect of Lactobacillus casei in petit-suisse cheese on the oral microbiota of children.", "results_summary": "The study assessed the feasibility of adding Lactobacillus casei to petit-suisse over 28 days and monitored changes in saliva microbiota before, during, and after consumption. Lactic bacteria remained viable, but specific efficacy outcomes were not detailed in the abstract.", "population_specificity": "Children", "effective_dosage": "Not specified", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:58.033141+00:00"}
{"study_id": 72000, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of Lactobacillus Casei (Lc) on clinical symptoms, intestinal microbiota, and inflammatory markers in children with acute diarrhea.", "results_summary": "The study found that Lc increased fecal IgA levels and downregulated fecal lactoferrin and calprotectin, suggesting reduced intestinal inflammation and improved immune response during acute diarrhea.", "population_specificity": "Children with acute diarrhea (specific age range not provided in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:58.718933+00:00"}
{"study_id": 72002, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential role of probiotics, particularly Lactobacillus casei, in preventing and treating breast cancer, as well as alleviating chemotherapy-induced side effects.", "results_summary": "In vitro and animal studies showed Lactobacillus casei induced cancer cell apoptosis, inhibited tumor growth, and exhibited immunomodulatory effects. Human studies suggested reduced breast cancer incidence with Lactobacillus casei consumption, but no curative role was confirmed.", "population_specificity": "Human, animal, and in vitro studies (no specific human subpopulation detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:59.564560+00:00"}
{"study_id": 72003, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of synbiotic supplementation, including Lactobacillus Casei, on metabolic profiles in diabetic patients undergoing hemodialysis.", "results_summary": "The study found that synbiotic supplementation, containing Lactobacillus Casei, improved metabolic profiles in diabetic hemodialysis patients, though specific results for Lactobacillus Casei alone were not detailed.", "population_specificity": "Diabetic patients undergoing hemodialysis (n=60).", "effective_dosage": "2 \u00d7 10^9 CFU (combined with other probiotics).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:01.325662+00:00"}
{"study_id": 72004, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine the sensitivity of Lactobacillus casei to photodynamic therapy (photosensitization) compared to other cariogenic bacteria in both planktonic and biofilm forms.", "results_summary": "The study found that Lactobacillus casei showed significant reductions in viability (30% in planktonic form, 13% in sessile form) when exposed to photodynamic therapy, indicating it was effectively targeted by the treatment. The effect was comparable to other cariogens except Streptococcus salivarius, which was minimally affected.", "population_specificity": "Human dentine biofilms and planktonic bacterial cultures.", "effective_dosage": "Not specified (exposure to Toluidine blue O and 1-minute laser treatment).", "study_duration": "1-minute laser exposure after photosensitizer application.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:03.986032+00:00"}
{"study_id": 72005, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of probiotic supplementation, including Lactobacillus Casei, on genetic and metabolic profiles in patients with gestational diabetes mellitus (GDM) not on oral hypoglycemic agents.", "results_summary": "The study found that probiotic supplementation improved genetic and metabolic profiles in GDM patients, though specific outcomes for Lactobacillus Casei alone were not detailed. The results suggest a beneficial effect of the probiotic blend.", "population_specificity": "48 patients with gestational diabetes mellitus (GDM) not on oral hypoglycemic agents.", "effective_dosage": "2 \u00d7 10^9 CFU per capsule (combined with other probiotics).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:04.759952+00:00"}
{"study_id": 72006, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Lactobacillus Casei, in combination with isoflavones, could improve genitourinary symptoms in postmenopausal women compared to hormone therapy.", "results_summary": "The study found that probiotics (including Lactobacillus Casei) improved the metabolism of isoflavones but did not significantly relieve urogenital symptoms or produce an estrogenic effect on the urogenital tract.", "population_specificity": "Postmenopausal women aged 40-60 years.", "effective_dosage": "Not specified for Lactobacillus Casei individually; administered as part of a multi-strain probiotic blend.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:04.874391+00:00"}
{"study_id": 72007, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the effect of oral administration of Lactobacillus casei Shirota (LcS) on pain relief in patients with single rib fractures.", "results_summary": "Patients receiving LcS experienced more effective pain relief during deep breathing, coughing, and turning over compared to placebo, along with a larger increase in SMI lung volume. Sleep quality did not significantly improve after 1 month of LcS treatment.", "population_specificity": "Patients with a single rib fracture.", "effective_dosage": "Skimmed milk containing commercial probiotic LcS, administered daily (exact dosage not specified).", "study_duration": "1 month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:05.149991+00:00"}
{"study_id": 72010, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of a synbiotic supplement containing Lactobacillus casei on improving atopic dermatitis symptoms in children.", "results_summary": "The study found significant improvements in AD symptoms, with reductions in SCORAD index, pruritus, and sleep disturbance scores. Higher baseline severity and adherence were predictive of greater improvement.", "population_specificity": "320 children aged 0-12 years with atopic dermatitis.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:07.316005+00:00"}
{"study_id": 72009, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether synbiotics containing Lactobacillus casei could modulate gut microbiota and reduce infectious complications in mechanically ventilated sepsis patients.", "results_summary": "The study found that synbiotics significantly reduced the incidence of enteritis and ventilator-associated pneumonia (VAP) and increased fecal Bifidobacterium and Lactobacillus counts, but did not affect bacteremia or mortality.", "population_specificity": "Mechanically ventilated sepsis patients in the ICU.", "effective_dosage": "Daily synbiotics (Bifidobacterium breve strain Yakult, Lactobacillus casei strain Shirota, and galactooligosaccharides).", "study_duration": "Administered within 3 days of admission and continued for up to 4 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:07.373912+00:00"}
{"study_id": 72008, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether yogurt supplemented with Lactobacillus casei subsp. casei Lc-01, in combination with other probiotics, could prevent antibiotic-associated diarrhea in hospitalized patients.", "results_summary": "The study found no significant difference in diarrhea rates between the probiotic and placebo groups, indicating that Lactobacillus casei, combined with other strains, did not effectively prevent antibiotic-associated diarrhea. All-cause mortality and diarrhea duration were also similar across groups.", "population_specificity": "Hospitalized patients (mean age 76 years) starting antibiotic treatment.", "effective_dosage": "200 mL daily of probiotic yogurt containing Lactobacillus casei subsp. casei Lc-01, administered within 48 hours of antibiotic initiation and continued for up to 5 days after stopping antibiotics.", "study_duration": "Intervention lasted from antibiotic initiation until 5 days post-antibiotic cessation, with follow-up for 1 month.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:07.875159+00:00"}
{"study_id": 72011, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of probiotic yogurt containing Lactobacillus casei DN001, along with a low-calorie diet, on serum adipokine concentrations (omentin-1, adropin, and nesfatin-1) in obese and overweight individuals.", "results_summary": "The study found that probiotic yogurt with Lactobacillus casei DN001, combined with a low-calorie diet, influenced serum adipokine concentrations, though specific results for Lactobacillus casei alone were not detailed in the abstract.", "population_specificity": "Obese or overweight individuals aged 20-50 years.", "effective_dosage": "Not specified (probiotic yogurt containing Lactobacillus casei DN001 was used, but exact dosage not detailed).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:10.690750+00:00"}
{"study_id": 72012, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether synbiotics therapy (including Lactobacillus Casei) had a preventive association against septic complications in mechanically ventilated critically ill patients.", "results_summary": "The study found that synbiotics therapy significantly reduced the incidence of enteritis and pneumonia but did not affect bacteremia rates. The odds ratios for diarrhea-free and pneumonia-free days were significantly higher in the synbiotics group.", "population_specificity": "Mechanically ventilated critically ill patients.", "effective_dosage": "Not specified (synbiotics included Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides, administered within 3 days of admission).", "study_duration": "Evaluated over the first 28 days after admission.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:12.462704+00:00"}
{"study_id": 72014, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Lactobacillus casei on glycemic control and serum levels of SIRT1 and fetuin-A in patients with type 2 diabetes mellitus (T2DM).", "results_summary": "Lactobacillus casei supplementation significantly reduced fasting blood sugar, insulin concentration, and insulin resistance, and increased SIRT1 while decreasing fetuin-A levels, improving glycemic response in T2DM patients.", "population_specificity": "Forty patients with type 2 diabetes mellitus (20 in the intervention group, 20 in the placebo group).", "effective_dosage": "10^8 cfu of L. casei daily.", "study_duration": "Eight weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:12.627822+00:00"}
{"study_id": 72015, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the clinical efficacy and safety of a probiotic formulation containing Lactobacillus casei LBC80R for preventing Clostridium difficile infection (CDI) in healthcare settings.", "results_summary": "The study found that the probiotic formulation, including Lactobacillus casei, demonstrated efficacy in reducing CDI incidence rates, supported by randomized controlled trials and facility-level interventions. It also highlighted an excellent safety and tolerability profile.", "population_specificity": "Patients receiving antibiotics in healthcare settings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:12.706426+00:00"}
{"study_id": 72017, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the effects of probiotic treatments, including Lactobacillus casei strain Shirota, on patients with fibromyalgia syndrome (FMS) or chronic fatigue syndrome (CFS).", "results_summary": "Lactobacillus casei strain Shirota reduced anxiety scores and altered fecal composition in CFS patients after 8 weeks of treatment. The probiotic demonstrated significant effects on modulating anxiety and inflammatory processes.", "population_specificity": "Patients diagnosed with chronic fatigue syndrome (CFS).", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:15.217579+00:00"}
{"study_id": 72019, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether perioperative administration of symbiotics, including Lactobacillus Casei, reduces surgical wound infection rates in colorectal cancer surgery patients.", "results_summary": "The study found that symbiotics significantly reduced surgical site infections (2% vs. 21.4% in the placebo group) and other postoperative infections (none in the symbiotics group vs. multiple in the control group).", "population_specificity": "Colorectal cancer patients undergoing elective surgery.", "effective_dosage": "Lactobacillus Casei 10^8 to 10^9 CFU, administered alongside other probiotics and FOS for five days pre-surgery and 14 days post-surgery.", "study_duration": "19 days (5 pre-surgery + 14 post-surgery).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:16.228459+00:00"}
{"study_id": 72018, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of synbiotic supplementation, including Lactobacillus casei, on glycemic control and lipid profiles in women with PCOS.", "results_summary": "The study evaluated synbiotic supplementation's impact but did not isolate Lactobacillus casei's specific effects; overall, it aimed to improve glycemic and lipid outcomes in PCOS patients.", "population_specificity": "Women with polycystic ovary syndrome (PCOS)", "effective_dosage": "Not specified (synbiotic capsule contained multiple strains, dosage not detailed in abstract)", "study_duration": "April 2017 to June 2017 (approximately 2 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:16.630124+00:00"}
{"study_id": 72020, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine the effects of fermented soymilk with Lactobacillus casei Shirota (LcS) on skin condition, gut microbiota, and isoflavone bioavailability in healthy premenopausal women.", "results_summary": "Both fermented soymilk (FSM) with LcS and regular soymilk (SM) improved skin condition and increased urinary isoflavone levels, but only FSM significantly modified gut microbiota by increasing Lactobacillaceae and reducing Enterobacteriaceae and Porphyromonadaceae.", "population_specificity": "Healthy premenopausal Japanese women (n=60).", "effective_dosage": "Twice daily for 8 weeks (exact dosage not specified).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:19.145621+00:00"}
{"study_id": 72022, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to assess whether symbiotics containing Lactobacillus Casei improved nutritional status, biochemical data, and intestinal function in patients with chronic pancreatitis.", "results_summary": "The study found that symbiotics significantly improved hemoglobin, hematocrit, red blood cells, total lymphocyte count, serum magnesium, and albumin levels while reducing total serum cholesterol. No significant changes were observed in nutritional status for either group.", "population_specificity": "Patients with chronic pancreatitis (60 participants).", "effective_dosage": "12 g/day of symbiotics (containing Lactobacillus Casei, Lactobacillus rhamnosus, Lactobacillus acidophilus, Bifidobacterium bifidum, and fructooligosaccharides).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:20.927075+00:00"}
{"study_id": 72023, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether a probiotic mixture containing Lactobacillus casei CECT 9104 is safe and effective in reducing atopic dermatitis symptoms and topical steroid use in children.", "results_summary": "The probiotic mixture significantly reduced the SCORAD index by 83% in the treatment group compared to 24% in the placebo group and decreased topical steroid use by 7.7% versus 10.8% in controls.", "population_specificity": "Children aged 4 to 17 years with moderate atopic dermatitis.", "effective_dosage": "10^9 total colony-forming units daily (combined with Bifidobacterium lactis CECT 8145 and B. longum CECT 7347).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:21.387000+00:00"}
{"study_id": 72021, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a multi-strain probiotic supplement, including Lactobacillus Casei, could improve circulating endotoxin levels and cardiometabolic biomarkers in patients with type 2 diabetes mellitus (T2DM).", "results_summary": "The study found no significant difference in endotoxin levels between the probiotics and placebo groups. However, the probiotics group showed a modest improvement in waist-to-hip ratio (WHR) and a clinically significant improvement in HOMA-IR, indicating better insulin sensitivity.", "population_specificity": "78 adult Saudi patients with T2DM who were medication-na\u00efve and without comorbidities.", "effective_dosage": "2.5 \u00d7 10^9 CFU twice daily (specific strain breakdown not detailed in abstract).", "study_duration": "12/13 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:21.754974+00:00"}
{"study_id": 72027, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Lactobacillus, including Lactobacillus Casei, on weight loss and/or fat mass in overweight adults.", "results_summary": "The study found that Lactobacillus Casei, when combined with phenolic compounds, showed beneficial effects on weight loss and/or fat mass, though results were strain-dependent. Some studies reported no effect or weight gain, indicating variability in outcomes.", "population_specificity": "Overweight adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:23.564593+00:00"}
{"study_id": 72013, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a combination of Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 could relieve symptoms of irritable bowel syndrome (IBS) compared to placebo.", "results_summary": "The study compared the probiotic combination to placebo in 113 subjects over 12 weeks, but the abstract does not specify the exact outcomes regarding Lactobacillus casei's effects on IBS symptoms.", "population_specificity": "113 subjects with irritable bowel syndrome (IBS) across 3 clinical sites.", "effective_dosage": "2 capsules containing 50\u00d710^9 CFU (exact dosage per strain not specified).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:23.971110+00:00"}
{"study_id": 72024, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of synbiotic supplementation, including Lactobacillus casei, on carotid intima-media thickness (CIMT), inflammation, and oxidative stress in individuals with overweight, diabetes, and coronary heart disease (CHD).", "results_summary": "The study assessed synbiotic supplementation's impact on CIMT, inflammation, and oxidative stress, but specific results for Lactobacillus casei alone were not detailed in the abstract.", "population_specificity": "Individuals aged 50-85 with overweight, diabetes, and CHD.", "effective_dosage": "2 \u00d7 10^? CFU (exact dosage unclear from abstract).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:24.744952+00:00"}
{"study_id": 72026, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of probiotic supplementation, including Lactobacillus casei, on gene expression related to inflammation, insulin, and lipids in patients with multiple sclerosis (MS).", "results_summary": "Probiotic supplementation significantly down-regulated gene expression of IL-8 and TNF-\u03b1 but had no significant effect on IL-1, PPAR-\u03b3, or LDLR in MS patients.", "population_specificity": "40 patients with multiple sclerosis.", "effective_dosage": "2 \u00d7 10^9 CFU (combined with other probiotics).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:24.924837+00:00"}
{"study_id": 72028, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effect of Lactobacillus casei Shirota (LcS) on pain, inflammation, and functional outcomes in patients with knee osteoarthritis.", "results_summary": "LcS significantly improved WOMAC and VAS scores and reduced serum hs-CRP levels compared to placebo, suggesting it may be a therapeutic option for knee OA by reducing inflammation.", "population_specificity": "537 patients with knee osteoarthritis", "effective_dosage": "Skimmed milk containing LcS daily (exact dosage not specified)", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:26.112930+00:00"}
{"study_id": 72030, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 92, "quality_score": 88, "study_goal": "The researchers aimed to determine the effectiveness of Lactobacillus casei as a probiotic supplement in triple therapy for improving H. pylori eradication rates and reducing side effects in pediatric patients.", "results_summary": "Lactobacillus casei was identified as the best probiotic for increasing H. pylori eradication rates (P score = 0.84) and was part of multi-strain combinations effective in reducing specific side effects like diarrhea and taste disturbance.", "population_specificity": "Pediatric patients with Helicobacter pylori infection.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:28.785025+00:00"}
{"study_id": 72031, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of Lactobacillus casei strain Shirota (LcS)-containing beverages on intestinal microbiota, organic acid levels, and body weight in obese children.", "results_summary": "The study found significant reductions in fecal Bifidobacterium levels in obese children compared to controls. After a 6-month intervention with LcS beverages alongside diet and exercise, body weight and serological markers were monitored, though specific outcomes were not detailed in the abstract.", "population_specificity": "Obese children (average age 10.8 years, BMI Z score 2.7\u00b11.7) and non-obese controls (average age 8.5 years, BMI Z score 0.1\u00b10.7).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:31.145989+00:00"}
{"study_id": 72034, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a probiotic mixture containing Lactobacillus casei could reduce the duration of blood in diarrhea and hospitalization in patients with acute dysentery.", "results_summary": "The study found that probiotic consumers had significantly shorter durations of blood in diarrhea (2.62 vs. 3.16 days) and hospitalization (3.16 vs. 3.66 days) compared to the control group, suggesting effectiveness in reducing dysentery symptoms.", "population_specificity": "Patients with acute dysentery", "effective_dosage": "High amounts of 7-strain probiotics (Kidilact\u00ae sachet) daily", "study_duration": "5 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:31.864751+00:00"}
{"study_id": 72033, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of probiotic supplementation, including Lactobacillus Casei, on inflammation, oxidative stress, and pregnancy outcomes in women with gestational diabetes.", "results_summary": "Probiotic supplementation significantly improved fasting plasma glucose, reduced inflammation (hs-CRP), and enhanced antioxidant capacity (TAC) while lowering oxidative stress markers (MDA), but did not affect pregnancy outcomes.", "population_specificity": "60 women with gestational diabetes not on oral hypoglycemic agents.", "effective_dosage": "2 \u00d7 10^9 CFU/day (combined with Lactobacillus acidophilus and Bifidobacterium bifidum).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:31.928361+00:00"}
{"study_id": 72035, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to assess the effectiveness of Lactobacillus casei rhamnosus Lcr35 in managing functional constipation in children under 5 years.", "results_summary": "The study found no significant difference in treatment success between the Lcr35 and placebo groups. Both groups showed increased defecation frequency, but the placebo group had significantly greater improvement than the Lcr35 group.", "population_specificity": "Children under 5 years with functional constipation (Rome III criteria).", "effective_dosage": "8 \u00d7 10^8 CFU/day (exact frequency not specified).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:32.986270+00:00"}
{"study_id": 72036, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 76, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of probiotics, particularly Lactobacillus casei rhamnosus (LCA), on the prevention of respiratory tract infections (RTIs) in children and adolescents.", "results_summary": "The study found that LCA was the only probiotic effective in reducing the rate of RTIs compared to placebo, with a relative risk of 0.38. However, network analysis showed no superior effect of LCA compared to other probiotic strains in indirect analysis.", "population_specificity": "Children and adolescents", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:33.886030+00:00"}
{"study_id": 72037, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of probiotic supplementation (including Lactobacillus Casei) on glycemic control, lipid concentrations, and biomarkers of inflammation and oxidative stress in diabetic hemodialysis patients.", "results_summary": "Probiotic supplementation significantly improved fasting plasma glucose, serum insulin, insulin resistance, and antioxidant capacity while reducing inflammation and oxidative stress markers compared to placebo.", "population_specificity": "60 diabetic patients on hemodialysis, matched by sex, dialysis duration, diabetes duration, BMI, and age.", "effective_dosage": "Not specified (capsule containing Lactobacillus acidophilus, Lactobacillus casei, and Bifidobacterium bifidum).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:34.195076+00:00"}
{"study_id": 72038, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of a synbiotic preparation containing Lactobacillus casei on the duration of diarrhea in children compared to zinc and standard therapy.", "results_summary": "The synbiotic preparation significantly reduced the duration of diarrhea compared to the control group, though it was similarly effective to zinc. Zinc showed better outcomes at 72 and 96 hours.", "population_specificity": "Children with acute infectious diarrhea.", "effective_dosage": "Synbiotic preparation (specific dosage not detailed) administered for 5 days.", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:36.217150+00:00"}
{"study_id": 72029, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy of a synbiotic containing Lactobacillus casei in treating functional constipation in children.", "results_summary": "The synbiotic group showed significant improvement in weekly defecations, abdominal pain, painful defecation, and pediatric Bristol scale compared to the placebo group, with 66.7% achieving complete benefit.", "population_specificity": "Children aged 4-18 years diagnosed with functional constipation.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:37.969252+00:00"}
{"study_id": 72040, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the scientific evidence supporting health claims for products containing Lactobacillus casei and compare published literature with corporate advertising.", "results_summary": "The study found insufficient scientific evidence to support health claims for Lactobacillus casei, with only 25% of included studies meeting high evidence standards (level 1b, grade A). Most studies lacked robust evidence, and corporate websites omitted some published studies.", "population_specificity": "Healthy human population", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:38.359164+00:00"}
{"study_id": 72041, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of synbiotic supplementation (including Lactobacillus casei) on markers of insulin metabolism and lipid profiles in patients with gestational diabetes mellitus (GDM).", "results_summary": "Synbiotic supplementation significantly improved insulin sensitivity, reduced insulin resistance, and lowered serum TAG and VLDL-cholesterol concentrations in GDM patients compared to placebo.", "population_specificity": "70 patients with GDM aged 18-40 years.", "effective_dosage": "2\u00d710^9 colony-forming units/g of Lactobacillus casei (combined with other strains) plus 800 mg inulin daily.", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:39.616292+00:00"}
{"study_id": 72042, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a fermented milk product containing Lactobacillus casei CNCM I-1518 could reduce the incidence of respiratory and gastrointestinal common infectious diseases (CIDs) in children attending day-care centers.", "results_summary": "The study found no significant difference in overall CID incidence between the fermented milk and control groups, but a significantly lower incidence of rhinopharyngitis was observed in the Lactobacillus casei group over the entire study period. No severe cases were reported, and no differences were found in disease duration, severity, or quality-of-life measures.", "population_specificity": "Children aged 3 to 6 years attending day-care centers in Russia.", "effective_dosage": "100 g of fermented milk product twice daily.", "study_duration": "3 months of intervention followed by a 1-month observation period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:40.871134+00:00"}
{"study_id": 72043, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of multispecies probiotic supplementation, including Lactobacillus Casei, on metabolic status in pregnant women during the first half of pregnancy.", "results_summary": "The study found that probiotic supplementation significantly improved markers of insulin metabolism, reduced triglycerides, and decreased inflammation and oxidative stress compared to placebo. However, changes in plasma glutathione (GSH) were not significant after adjusting for baseline levels, age, and BMI.", "population_specificity": "Pregnant women aged 18-37 years in the first half of pregnancy (9 weeks gestation at study start).", "effective_dosage": "2 \u00d7 10^9 CFU/g each of Lactobacillus acidophilus, Lactobacillus casei, and Bifidobacterium bifidum.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:41.852108+00:00"}
{"study_id": 72044, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antibacterial potential of a dentifrice containing Eugenia uniflora extract against oral pathogens, including Lactobacillus casei, and compare its clinical efficacy to a triclosan-based dentifrice in treating gingivitis in children.", "results_summary": "The experimental dentifrice showed efficient antibacterial activity against Lactobacillus casei in vitro. However, the clinical trial primarily focused on gingivitis outcomes, with no specific results reported for Lactobacillus casei's effects in vivo.", "population_specificity": "Children aged 10-12 years with clinical signs of gingivitis.", "effective_dosage": "Not specified for Lactobacillus casei.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:42.250911+00:00"}
{"study_id": 72045, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effect of probiotic treatment (Lactobacillus casei Shirota) on functional recovery in elderly patients with distal radius fractures.", "results_summary": "The study found that patients receiving Lactobacillus casei Shirota showed significantly faster improvement in DASH score, pain, CRPS score, wrist flexion, and grip strength compared to placebo, achieving comparable outcomes by month 4 that placebo patients reached by month 6.", "population_specificity": "Elderly patients (n=417) with acute distal radius fractures.", "effective_dosage": "Daily administration in skimmed milk (exact dosage not specified).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:42.332149+00:00"}
{"study_id": 72046, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 65, "quality_score": 90, "study_goal": "The researchers aimed to assess the health and immune benefits of consuming Lactobacillus casei Shirota in highly physically active individuals, focusing on upper respiratory tract infection symptoms and viral antibody levels.", "results_summary": "The study found no significant difference in upper respiratory tract infection incidence, duration, or severity between the probiotic and placebo groups. However, the probiotic reduced plasma CMV and EBV antibody titres in seropositive participants, suggesting a potential immune benefit.", "population_specificity": "University athletes and games players (n=243).", "effective_dosage": "Daily ingestion (specific amount not stated).", "study_duration": "20 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:45.089915+00:00"}
{"study_id": 72048, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine whether daily consumption of Lactobacillus casei strain Shirota could relieve stress-associated abdominal dysfunction and preserve gut microbiota diversity in healthy subjects under stress.", "results_summary": "The study found that L. casei strain Shirota significantly suppressed stress-induced increases in abdominal dysfunction, reduced gastrointestinal symptoms, preserved gut microbiota diversity, and lowered salivary cortisol levels compared to placebo.", "population_specificity": "Healthy medical students under examination stress conditions.", "effective_dosage": "Daily consumption of L. casei strain Shirota-fermented milk (exact dosage not specified).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:45.894863+00:00"}
{"study_id": 72049, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of probiotic supplementation, including Lactobacillus Casei, on clinical and metabolic outcomes in patients with rheumatoid arthritis (RA).", "results_summary": "Probiotic supplementation improved Disease Activity Score (DAS-28), reduced serum insulin levels, HOMA-B, and hs-CRP concentrations, with borderline significant effects on cholesterol levels compared to placebo.", "population_specificity": "Patients with rheumatoid arthritis aged 25-70 years.", "effective_dosage": "2 \u00d7 10(9) CFU/g of Lactobacillus Casei daily (combined with other strains).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:46.726190+00:00"}
{"study_id": 72050, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to determine whether Lactobacillus casei strain Shirota (LcS) could mitigate stress-induced psychological and physiological responses via gut-brain interactions.", "results_summary": "LcS significantly reduced stress-induced cortisol levels and physical symptoms in humans and suppressed stress-related biomarkers in rats, likely through vagal afferent signaling and reduced hypothalamic stress reactivity.", "population_specificity": "Healthy medical students under academic stress and rats subjected to water avoidance stress.", "effective_dosage": "LcS-fermented milk daily (exact dosage not specified).", "study_duration": "8 weeks for humans, 2 weeks for rats.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:47.686297+00:00"}
{"study_id": 72051, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of probiotic supplementation (including Lactobacillus Casei) on symptoms of depression and metabolic status in patients with major depressive disorder (MDD).", "results_summary": "Probiotic supplementation significantly improved depression symptoms, reduced serum insulin levels, insulin resistance, and hs-CRP concentrations, and increased glutathione levels, but did not affect fasting glucose, lipid profiles, or total antioxidant capacity.", "population_specificity": "40 patients aged 20-55 with MDD diagnosed via DSM-IV criteria.", "effective_dosage": "2 \u00d7 10^9 CFU/g of Lactobacillus Casei (combined with other strains), administered daily.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:49.454468+00:00"}
{"study_id": 72052, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether daily consumption of Lactobacillus casei strain Shirota (LcS) could mitigate psychological, physiological, and physical stress responses in medical students undergoing a high-stakes examination.", "results_summary": "The study found that LcS consumption reduced stress-related physiological markers (e.g., cortisol and L-tryptophan levels) and physical symptoms (e.g., abdominal and cold symptoms) compared to placebo, with significant improvements in faecal serotonin levels post-examination.", "population_specificity": "Healthy medical students preparing for a nationwide promotion examination.", "effective_dosage": "Fermented milk containing LcS, once daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:50.342918+00:00"}
{"study_id": 72054, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the effectiveness of different antimicrobial therapies, including their impact on Lactobacillus casei levels in deep carious dentin lesions.", "results_summary": "The study found that all tested therapies effectively reduced the number of Lactobacillus casei in carious dentin, with no significant differences among the protocols. No adverse effects or restoration failures were reported.", "population_specificity": "32 children aged 5 to 7 years with deep carious dentin lesions in primary molars.", "effective_dosage": "Not specified", "study_duration": "Follow-ups at 6 and 12 months post-treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:51.760224+00:00"}
{"study_id": 72056, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of Lactobacillus casei Shirota (LcS) on symptoms and quality of life in IBS patients.", "results_summary": "After 8 weeks, LcS did not achieve a 30% improvement in symptom scores, but by week 16, the probiotic group showed a mean improvement of 34%, though this was not significantly different from the placebo group.", "population_specificity": "IBS patients (Rome II criteria) aged 18-65 years.", "effective_dosage": "Twice daily (specific amount not stated).", "study_duration": "8-week intervention, followed by an 8-week follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:54.654533+00:00"}
{"study_id": 72057, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Lactobacillus casei strain Shirota-fermented milk (LcS-FM) on the incidence of upper respiratory tract infections (URTIs) in healthy middle-aged office workers.", "results_summary": "The study found that the incidence of URTIs was significantly lower in the LcS-FM group (22.4%) compared to the control group (53.2%), with a higher URTI-free rate over the test period, suggesting LcS-FM may reduce URTI risk through immune modulation.", "population_specificity": "Healthy male office workers aged 30-49 years.", "effective_dosage": "1.0 \u00d7 10^8 CFU/day (frequency not specified).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:55.498818+00:00"}
{"study_id": 72058, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether adding Lactobacillus casei DG to a levofloxacin-doxycycline triple therapy improved H. pylori eradication rates and tolerability in non-responders.", "results_summary": "The study found that adding Lactobacillus casei DG increased H. pylori eradication rates (55% vs. 43% per protocol) and improved tolerability, with side effects generally mild.", "population_specificity": "142 non-responders (99 women, 43 men; mean age 53.0 \u00b1 12.7 years) to previous H. pylori eradication therapies.", "effective_dosage": "Not specified for Lactobacillus casei DG.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:55.868917+00:00"}
{"study_id": 72055, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a fermented milk drink containing Lactobacillus casei Shirota (LcS) could prevent aflatoxin absorption and reduce serum aflatoxin B1-lysine adduct (AFB1-lys) and urinary aflatoxin M1 concentrations.", "results_summary": "The study found no significant differences in aflatoxin biomarker concentrations overall, but within-group analysis showed a significant reduction in AFB1-lys concentrations in one group (Blue group) after probiotic intervention, particularly at the 2nd and 4th weeks compared to baseline and placebo.", "population_specificity": "Seventy-one subjects recruited from a screening stage, divided into two groups (Yellow and Blue).", "effective_dosage": "Probiotic drinks twice a day.", "study_duration": "Two 4-week intervention phases with a 2-week wash-out period in between.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:55.926839+00:00"}
{"study_id": 72060, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and clinical benefits of a probiotic formulation containing Lactobacillus casei LBC80R in reducing antibiotic-associated diarrhea and Clostridium difficile infection (CDI).", "results_summary": "The study demonstrated that the probiotic formulation, including Lactobacillus casei, reduced incidences of antibiotic-associated diarrhea and CDI, showed antimicrobial activity against C. difficile, and neutralized toxins A/B in vitro. The strains and products were also confirmed to be safe, stable, and capable of surviving gastrointestinal transit.", "population_specificity": "Human clinical trial participants (specific population details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:58.164903+00:00"}
{"study_id": 72061, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a multispecies probiotic containing Lactobacillus casei W56 could reduce cognitive reactivity to sad mood in non-depressed individuals.", "results_summary": "The study found that participants who received the 4-week multispecies probiotic intervention showed significantly reduced overall cognitive reactivity to sad mood, particularly in rumination and aggressive thoughts, compared to the placebo group.", "population_specificity": "20 healthy participants without current mood disorder (plus 20 controls).", "effective_dosage": "Not specified (multispecies probiotic formulation).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:59.229682+00:00"}
{"study_id": 72059, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the clinical effectiveness of NanoAg-IS-PMMA and NanoAg-I-PMMA in inhibiting the planktonic growth and biofilm formation of cariogenic bacteria, including Lactobacillus casei, in orthodontic patients.", "results_summary": "NanoAg-IS-BOA showed strong anti-biofilm effects against Lactobacillus casei, inhibiting biofilm formation by 20.1 to 79.9% compared to the control. NanoAg-IS-BOA demonstrated higher antibacterial activity than NanoAg-I-BOA throughout the trial.", "population_specificity": "24 patients aged 7-15 years harboring cariogenic bacteria, including Lactobacillus casei.", "effective_dosage": "0.5% w/w NanoAg incorporated into BOA.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:59.403415+00:00"}
{"study_id": 72063, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of Lactobacillus casei Shirota in preventing antibiotic-associated diarrhoea (AAD) and Clostridium difficile diarrhoea (CDD) in older patients.", "results_summary": "The study found no preventive effect of Lactobacillus casei Shirota for AAD and CDD in older patients, aligning with the overall conclusion that probiotics may not reduce the risk of these conditions in this population.", "population_specificity": "Older patients (age \u226565 years)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:02.671937+00:00"}
{"study_id": 72062, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Lactobacillus casei 01 supplementation on oxidative stress indices in patients with rheumatoid arthritis (RA).", "results_summary": "The study found no significant effect of L. casei 01 supplementation on oxidative stress markers (MDA, TAC, CAT, SOD, GPx) in RA patients compared to placebo. SOD activity decreased in the probiotic group, and GPx activity decreased in both groups, but no significant between-group differences were observed.", "population_specificity": "46 patients with rheumatoid arthritis.", "effective_dosage": "10^8 CFUs of Lactobacillus casei 01 daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:02.967146+00:00"}
{"study_id": 72065, "supplement_id": 1274, "safety_score": "80", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine whether adding probiotics (including Lactobacillus casei) to standard triple therapy improves H. pylori eradication rates or reduces side effects in children.", "results_summary": "The study found no significant difference in H. pylori eradication rates (66.6% with probiotics vs. 68.9% without) or side effects between the groups, suggesting probiotics did not enhance treatment outcomes.", "population_specificity": "Symptomatic children aged 7-18 years with H. pylori infection.", "effective_dosage": "Not specified (probiotics included Lactobacillus casei, Lactobacillus acidophilus, and Bifidobacterium lactis).", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:04.207299+00:00"}
{"study_id": 72064, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether synbiotics containing Lactobacillus casei could reduce postoperative complications, infections, and mortality in patients undergoing surgery for periampullary neoplasms.", "results_summary": "The study found that synbiotics significantly reduced postoperative infections, antibiotic use, noninfectious complications, hospital stay, and mortality compared to placebo. Lactobacillus casei was part of the synbiotic formulation that demonstrated these benefits.", "population_specificity": "Patients undergoing surgery for periampullary neoplasms.", "effective_dosage": "1 \u00d7 10^9 CFU of Lactobacillus casei, twice daily, as part of a synbiotic blend.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:05.520014+00:00"}
{"study_id": 72066, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether probiotic Lactobacillus casei Shirota could reduce mutans streptococci counts in saliva, potentially aiding in dental caries prevention.", "results_summary": "The study found a statistically significant reduction (34%) in mutans streptococci colony counts in children consuming probiotic milk (p=.003), suggesting its effectiveness in lowering caries-related bacteria.", "population_specificity": "31 children in a double-blinded study.", "effective_dosage": "Not specified (probiotic milk administered for 10 days).", "study_duration": "10 days per intervention period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:05.661873+00:00"}
{"study_id": 72067, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the prophylactic efficacy of Lactobacillus casei rhamnosus against neomycin for preventing recurrent cholangitis in biliary atresia patients post-Kasai operation.", "results_summary": "Lactobacillus casei rhamnosus was as effective as neomycin in preventing cholangitis (20% incidence vs. 80% in controls) and improved weight gain. Stool cultures showed increased Lactobacillus and decreased Escherichia coli populations.", "population_specificity": "Jaundice-free biliary atresia patients aged 0-3 years who underwent Kasai operation.", "effective_dosage": "8 \u00d7 10^8 colony-forming units per day.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:07.862694+00:00"}
{"study_id": 72068, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether daily intake of Lactobacillus casei Shirota (LcS) reduces colonization of pathogens (streptococci and Staphylococcus aureus) in the nose and throat of healthy volunteers with low natural killer cell activity and influences salivary secretory immunoglobulin A (SIgA) production.", "results_summary": "The study found no statistically significant effect of LcS on the incidence of Staph. aureus or streptococci in the nasal or pharyngeal spaces, nor did it affect salivary SIgA production. The intervention did not influence nasopharyngeal colonization with Gram-positive potential pathogens.", "population_specificity": "Healthy human volunteers with low natural killer cell activity.", "effective_dosage": "Not specified (fermented milk drink with LcS).", "study_duration": "4-week intervention phase.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:08.576200+00:00"}
{"study_id": 72069, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cost-efficiency and effectiveness of Lactobacillus casei DN 114001 in reducing antibiotic-associated diarrhea (AAD) compared to another Lactobacillus casei strain (Shirota).", "results_summary": "The study found that Lactobacillus casei DN 114001 significantly reduced AAD incidence (6.5% vs. 28.4%) and shortened its duration, with notable cost savings. The other tested strain (Shirota) showed no advantages.", "population_specificity": "258 patients with infections in a primary care hospital in western Germany (107 received probiotics).", "effective_dosage": "At least 10 billion cultures of Lactobacillus casei DN 114001 twice daily.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:11.550732+00:00"}
{"study_id": 72070, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether conditioning intestinal dendritic cells (DC) with Lactobacillus casei Shirota could restore normal function in ulcerative colitis (UC) patients by modulating T-cell responses.", "results_summary": "Lactobacillus casei Shirota partially restored normal DC function in UC patients, reducing Toll-like receptor 2/4 expression and restoring the ability to imprint homing molecules on T cells and generate interleukin-22 production. This suggests that probiotic conditioning of DC may indirectly improve T-cell dysfunction in UC.", "population_specificity": "Humans with ulcerative colitis (UC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:11.813970+00:00"}
{"study_id": 72071, "supplement_id": 1274, "safety_score": "100", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the impact of Lactobacillus casei strain Shirota (LcS) on stool consistency, constipation-related symptoms, quality of life, and haemorrhoid incidence in postpartum women.", "results_summary": "The probiotic group showed improved scores for constipation-related symptoms and quality of life compared to placebo, with earlier recovery from haemorrhoids. No significant effect was observed on stool consistency or frequency, and no adverse events were reported.", "population_specificity": "Women during puerperium (postpartum period) who had natural childbirth.", "effective_dosage": "One bottle/day of fermented milk containing at least 6.5\u00d710^9 cfu of LcS.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:12.488353+00:00"}
{"study_id": 72072, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Lactobacillus casei DN-114001 improves H. pylori eradication rates and reduces side effects when used alongside antibiotic therapy.", "results_summary": "The study found that Lactobacillus casei DN-114001 significantly increased H. pylori eradication rates, particularly when antibiotic therapies were relatively ineffective. However, its impact on reducing side effects was inconclusive and only observed in non-blinded trials.", "population_specificity": "4,459 patients across 33 randomized controlled trials, focusing on H. pylori eradication therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:14.184405+00:00"}
{"study_id": 72073, "supplement_id": 1274, "safety_score": "100", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and clinical efficacy of an attenuated Lactobacillus casei expressing HPV16 E7 protein in patients with HPV16-associated CIN3.", "results_summary": "The study found that oral administration of the vaccine increased E7-specific mucosal immunity in cervical lesions, with 70% of patients on the optimized dose experiencing a pathological down-grade to CIN2. No adverse events were reported, and E7-CMI responses correlated with clinical improvement.", "population_specificity": "Patients with HPV16-associated cervical intraepithelial neoplasia grade 3 (CIN3).", "effective_dosage": "1, 2, 4, or 6 capsules/day (optimized dose was 4 capsules/day).", "study_duration": "9 weeks (vaccinations at weeks 1, 2, 4, and 8).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:14.492041+00:00"}
{"study_id": 72074, "supplement_id": 1274, "safety_score": "30", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers investigated whether a probiotic preparation containing Lactobacillus Casei was associated with Vancomycin-resistant Enterococcus (VRE) colonization in preterm infants.", "results_summary": "The study found that probiotic use and vancomycin exposure were significant risk factors for VRE colonization, suggesting that probiotics may mediate the acquisition and transfer of resistance genes. The outbreak's timing coincided with the probiotic trial, raising safety concerns.", "population_specificity": "Preterm infants with gestational age less than 32 weeks.", "effective_dosage": "Not specified (probiotic preparation included multiple strains and compounds).", "study_duration": "February 2012 to August 2013 (~18 months).", "interactions": "Vancomycin (increased risk of VRE colonization).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:15.911819+00:00"}
{"study_id": 72075, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of Lactobacillus Casei Shirota on gut transit time, stool output, and constipation symptoms in adults with functional constipation.", "results_summary": "The study found that Lactobacillus Casei Shirota did not significantly improve stool frequency (WMD: -0.2 bowel movements/wk) or stool consistency (SMD: +0.26) compared to controls. No serious adverse events were reported.", "population_specificity": "Adults with functional constipation.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:17.339171+00:00"}
{"study_id": 72077, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the efficacy of a synbiotic containing Lactobacillus casei and other probiotic strains in reducing infant crying time due to colic.", "results_summary": "The synbiotic group showed significantly higher treatment success (reduction in crying time >50%) and symptom resolution (reduction >90%) compared to placebo at day 7 and day 30, with no reported complications.", "population_specificity": "Breastfed infants aged 15-120 days with infantile colic.", "effective_dosage": "1 billion CFU per sachet, administered daily.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:19.749740+00:00"}
{"study_id": 72078, "supplement_id": 1274, "safety_score": "100", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of Lactobacillus casei 01 supplementation on symptoms and inflammatory biomarkers in women with rheumatoid arthritis.", "results_summary": "L. casei 01 supplementation reduced hs-CRP levels, tender and swollen joint counts, global health score, and DAS28, while improving inflammatory cytokines (IL-10, IL-12, TNF-\u03b1) and EULAR response rates compared to placebo.", "population_specificity": "Female RA patients aged 20-80 with BMI <40 and stable medication use for 3 months prior.", "effective_dosage": "10^8 CFU per capsule, daily for 8 weeks.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:20.216820+00:00"}
{"study_id": 72076, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if probiotic yogurt containing Lactobacillus casei DN001, combined with a weight-loss diet, could reduce proinflammatory markers and improve metabolic outcomes in overweight and obese individuals.", "results_summary": "The study found that probiotic yogurt with a low-calorie diet (PLCD) led to significant reductions in BMI, fat percentage, leptin levels, and ROR-\u03b3t gene expression compared to other groups. However, TNF-\u03b1 expression remained unchanged, and hs-CRP reduction was more evident in the group consuming probiotic yogurt without a diet (PWLCD).", "population_specificity": "Healthy overweight and obese individuals (n = 75).", "effective_dosage": "200 g/day of yogurt containing Lactobacillus casei DN001 (10^8 CFU/g), along with Lactobacillus acidophilus La5 and Bifidobacterium BB12.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:21.025866+00:00"}
{"study_id": 72080, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review how probiotics, including Lactobacillus casei Shirota, stimulate the immune system and their potential immunomodulatory effects.", "results_summary": "The study found that Lactobacillus casei Shirota, among other probiotics, can enhance nonspecific cellular immune responses, including macrophage and NK cell activation, and modulate cytokine production in a strain-specific and dose-dependent manner. Probiotic supplementation in infancy and pregnancy may influence immune parameters and prevent immune-mediated diseases.", "population_specificity": "General population, with specific mentions of infants and pregnant women.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:22.185871+00:00"}
{"study_id": 72079, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "To determine the effectiveness of two different doses of Lactobacillus Casei Shirota (LcS) in reducing urea concentrations by at least 10% in patients with stage 3 and 4 chronic kidney disease (CKD).", "results_summary": "The study found a significant decrease (>10%) in blood urea concentrations in patients treated with the higher dose (16 x 10^9 CFU) of LcS compared to baseline measurements. No significant effect was observed with the lower dose (8 x 10^9 CFU).", "population_specificity": "Outpatients with stage 3 and 4 CKD treated at the National Institute of Medical Sciences and Nutrition Salvador Zubir\u00e1n in Mexico.", "effective_dosage": "Group A: 8 x 10^9 CFU; Group B: 16 x 10^9 CFU.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:23.139882+00:00"}
{"study_id": 72053, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Lactobacillus casei strain Shirota (LcS)-fermented milk could normalize bowel movements and improve infection control in elderly residents and staff of elderly care facilities.", "results_summary": "The study found that LcS-fermented milk significantly reduced fever incidence, improved bowel movements, increased beneficial bacteria (Bifidobacterium and Lactobacillus), decreased harmful bacteria (Clostridium difficile), and elevated fecal acetic acid and total acidity compared to placebo. Similar benefits were observed in staff members.", "population_specificity": "Elderly residents (average age 85) and staff members (average age 37) of elderly care facilities.", "effective_dosage": "Once daily (specific volume not stated).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:23.940046+00:00"}
{"study_id": 72081, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether probiotic supplementation with Lactobacillus casei (Shirota strain) could reduce antibiotic-associated diarrhea (AAD) in elderly patients.", "results_summary": "The study found no significant difference in AAD incidence or duration between the Lactobacillus casei group (12.2% diarrhea) and the placebo group (8.7% diarrhea), with mean durations of 4 and 5 days, respectively. The low prevalence of AAD limited the study's ability to detect potential benefits.", "population_specificity": "Elderly patients (66-101 years old) admitted to Geriatric Evaluation Management wards.", "effective_dosage": "Not specified (active Yakult product used, but exact dosage not detailed).", "study_duration": "Not specified (study conducted during August-October 2009, but intervention duration unclear).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:25.510345+00:00"}
{"study_id": 72082, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize human clinical trials on Lactobacillus casei strain Shirota (LcS) for cancer prevention and discuss its immunomodulatory mechanisms.", "results_summary": "The study found that LcS has potential benefits in preventing immune-related diseases, including cancer, supported by science-based evidence. It also discusses possible immunomodulatory mechanisms for its anti-cancer activity.", "population_specificity": "Not specified (general human clinical trials)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:25.584983+00:00"}
{"study_id": 72083, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effects of Lactobacillus casei 01 supplementation on disease activity and inflammatory cytokines in patients with rheumatoid arthritis (RA).", "results_summary": "The study found that Lactobacillus casei 01 significantly reduced disease activity and decreased proinflammatory cytokines (TNF-\u03b1, IL-6, IL-12) while increasing the regulatory cytokine IL-10 in RA patients.", "population_specificity": "46 patients with rheumatoid arthritis.", "effective_dosage": "Minimum of 10^8 CFU of Lactobacillus casei 01 daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:27.554216+00:00"}
{"study_id": 72085, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the antibacterial activity of Lactobacillus casei against MRSA and its potential efficacy in decolonization or treatment of S. aureus infections.", "results_summary": "Lactobacillus casei demonstrated in vitro antibacterial activity against MRSA, mediated by competitive exclusion and production of inhibitory substances. However, in vivo efficacy varied, with some strains showing effectiveness in animal models while others did not.", "population_specificity": "Clinical MRSA isolates and animal models (mice).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:28.513831+00:00"}
{"study_id": 72084, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of Lactobacillus, specifically Lactobacillus casei, in preventing Clostridium difficile-associated diarrhea (CDAD).", "results_summary": "The meta-analysis found that Lactobacillus, particularly a combination of L. acidophilus and L. casei, significantly reduced the risk of CDAD (RR 0.05, 95% CI 0.01-0.36). Single regimens of other Lactobacillus strains did not show significant effects.", "population_specificity": "Subjects aged 4.15 to 64.75 years, with male proportions ranging from 42.0% to 59.1%.", "effective_dosage": "Total daily dose ranged from 1.2\u00d710^9 to 1.2\u00d710^12 CFU.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:29.496429+00:00"}
{"study_id": 72087, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of probiotic yogurt containing Lactobacillus casei DN001 on immune-related gene expression in overweight and obese individuals, both with and without a low-calorie diet.", "results_summary": "The study found that probiotic yogurt with Lactobacillus casei DN001, especially when combined with a low-calorie diet, significantly reduced ROR-\u03b3t and T-bet gene expression while increasing FOXP3 expression. IFN-\u03b3 expression decreased across all groups, but TNF-\u03b1, TGF-\u03b2, and GATA3 expression remained unchanged.", "population_specificity": "Overweight and obese individuals (BMI 25-35)", "effective_dosage": "200 g/day of yogurt containing Lactobacillus casei DN001 (10^8 CFU/g)", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:32.310455+00:00"}
{"study_id": 72089, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of self-ligating brackets and conventional brackets on dental plaque retention and microbial flora, including Lactobacillus casei.", "results_summary": "The study found no statistically significant difference in Lactobacillus casei levels between self-ligating and conventional brackets. All microorganisms, including L. casei, showed significant increases from baseline to 3 months after bonding in both groups.", "population_specificity": "Twenty boys with a mean age of 14.2 \u00b1 1.5 years.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:33.345461+00:00"}
{"study_id": 72086, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of Lactobacillus casei Shirota (LcS) in reducing antibiotic-associated diarrhoea (AAD) and Clostridium difficile-associated diarrhoea (CDAD) in spinal cord injury (SCI) patients, and to evaluate undernutrition and proton pump inhibitors (PPI) as risk factors.", "results_summary": "The LcS group had a significantly lower incidence of AAD (17.1% vs. 54.9%, P<0.001). Undernutrition and PPI use were associated with AAD, but no significant difference in nutrient intake was observed between groups. Poor appetite and no probiotic use were identified as independent risk factors for AAD.", "population_specificity": "Hospitalized spinal cord injury (SCI) patients requiring antibiotics.", "effective_dosage": "At least 6.5 \u00d7 10\u2079 live Lactobacillus casei Shirota (LcS) once daily.", "study_duration": "Duration of antibiotic course plus 7 days thereafter.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:33.604795+00:00"}
{"study_id": 72088, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effectiveness of Lactobacillus casei subsp. DG, alone or in combination with mesalazine, in maintaining remission of symptomatic uncomplicated diverticular disease (SUDD).", "results_summary": "The study found that Lactobacillus casei subsp. DG, particularly when combined with mesalazine, significantly reduced recurrence rates of SUDD compared to placebo. The combination group (LM) had no recurrences, while the Lactobacillus-only group (L) had a 14.5% recurrence rate, both outperforming placebo (46%).", "population_specificity": "Patients with symptomatic uncomplicated diverticular disease (SUDD) of the colon.", "effective_dosage": "24 billion/day of Lactobacillus casei subsp. DG.", "study_duration": "10 days/month for 12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:33.781695+00:00"}
{"study_id": 72090, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to determine whether daily consumption of a synbiotic yogurt containing Lactobacillus Casei CRL431, along with other probiotics and inulin, affects gastrointestinal function and dietary intake in healthy adults.", "results_summary": "The study found that the synbiotic yogurt did not significantly alter gastrointestinal transit time but was well tolerated and helped reduce overall energy intake, particularly in participants with shorter baseline transit times. No significant changes in GI symptoms were observed.", "population_specificity": "65 healthy adults, categorized into short (\u226432.7 h) and long (>32.7 h) gastrointestinal transit time groups.", "effective_dosage": "200 g/day of yogurt containing Lactobacillus Casei CRL431, Bifidobacterium lactis Bb12, Lactobacillus acidophilus La5, and 4 g inulin.", "study_duration": "Two 15-day treatment periods, each preceded by a 6-week washout.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:35.830089+00:00"}
{"study_id": 72091, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Lactobacillus casei CRL 431, when added to milk, could improve growth and iron and zinc status in Indonesian children compared to milk with regular calcium alone.", "results_summary": "Lactobacillus casei CRL 431 modestly improved monthly weight velocity but did not significantly affect height, anemia prevalence, or iron and zinc status. The effects were less pronounced than those observed with Lactobacillus reuteri DSM 17938.", "population_specificity": "Healthy children from low-socioeconomic urban communities in Jakarta, Indonesia (n = 494).", "effective_dosage": "5 \u00d7 10^8 CFU/d", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:36.127582+00:00"}
{"study_id": 72092, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy of Lactobacillus Casei in alleviating symptoms of irritable bowel syndrome (IBS), specifically distension and flatulence, as part of a broader meta-analysis on probiotics.", "results_summary": "Lactobacillus Casei improved distension scores (SMD, -0.53; 95% CI, -1.00; -0.06) and flatulence (SMD, -0.60; 95% CI, -1.07; -0.13) in IBS patients, indicating a statistically significant benefit for these symptoms.", "population_specificity": "IBS patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:36.892622+00:00"}
{"study_id": 72093, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of Lactobacillus casei strain Shirota in alleviating functional constipation in otherwise-healthy adults.", "results_summary": "The study found no significant improvement in constipation severity, stool frequency, consistency, or quantity compared to placebo at the 5% significance level, though re-evaluation at a 10% level showed slight improvement in constipation severity. Stool consistency showed a small but growing effect over time.", "population_specificity": "Adults with functional constipation (Rome II-defined).", "effective_dosage": "Once daily fermented milk containing L. casei strain Shirota (exact dosage not specified).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:38.610807+00:00"}
{"study_id": 72094, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to characterize the protective mechanisms of Lactobacillus casei/paracasei-produced lactocepin in reducing inflammation in experimental IBD models.", "results_summary": "The study found that lactocepin selectively degrades pro-inflammatory chemokines, leading to reduced immune cell infiltration and inflammation in IBD models, suggesting broad therapeutic potential for inflammatory diseases.", "population_specificity": "Experimental IBD models (not specified if human or animal).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:39.323587+00:00"}
{"study_id": 72095, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of a probiotic drink containing Lactobacillus casei Shirota (LcS) on immune function in a healthy older population.", "results_summary": "Probiotic consumption significantly increased natural killer (NK) cell activity and decreased CD25 expression in resting T cells compared to placebo. There was also a trend toward an increased anti-inflammatory cytokine profile (IL-10 to IL-12 ratio) after LcS intake.", "population_specificity": "Healthy, non-immunocompromised older volunteers (n=30).", "effective_dosage": "1.3 \u00d7 10^10 CFU LcS per day.", "study_duration": "4 weeks per treatment (with a 4-week washout period).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:41.874841+00:00"}
{"study_id": 72097, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Lactobacillus casei Shirota supplementation on insulin sensitivity, \u03b2-cell function, inflammation, and endothelial dysfunction in subjects with metabolic syndrome.", "results_summary": "The study found no significant improvements in insulin sensitivity, \u03b2-cell function, endothelial function, or inflammation markers, except for a reduction in soluble vascular cell adhesion molecule-1 (sVCAM-1) levels. The change in insulin sensitivity index was not significantly different compared to the control group.", "population_specificity": "Subjects with metabolic syndrome", "effective_dosage": "3 times daily for 12 weeks", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:41.991481+00:00"}
{"study_id": 72096, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate whether adding Lactobacillus casei to antibiotic treatment improved symptoms in patients with SIBO compared to prebiotics.", "results_summary": "Lactobacillus casei significantly improved 5 out of 6 symptoms in SIBO patients, showing a trend toward greater effectiveness than prebiotics, though the difference was not statistically significant.", "population_specificity": "40 patients (14 males, 26 females) with SIBO and abdominal complaints but no gastrointestinal diseases or alarm symptoms.", "effective_dosage": "Lactobacillus casei administered for 7 days following 7 days of Rifaximin 400 mg/day.", "study_duration": "6-month follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:42.930877+00:00"}
{"study_id": 72098, "supplement_id": 1274, "safety_score": "95", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to determine if a probiotic mixture containing Lactobacillus Casei was effective in treating constipation during pregnancy.", "results_summary": "The probiotic mixture significantly increased defecation frequency and reduced symptoms like anorectal obstruction, incomplete evacuation, straining, abdominal pain, and reflux episodes. No side effects were reported.", "population_specificity": "Pregnant women aged \u226518 years with functional constipation.", "effective_dosage": "4*10\u2079 CFU daily (Ecologic\u00aeRelief containing multiple strains, including Lactobacillus casei W79).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:43.432553+00:00"}
{"study_id": 72100, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "To assess the effects and safety of Lactobacillus casei rhamnosus LCR35 in patients with irritable bowel syndrome (IBS).", "results_summary": "LCR35 showed potential efficacy in IBS patients with diarrhea, with a clinically relevant decrease in symptom severity, but no significant difference was observed in the overall population. No clinically relevant changes were noted in quality of life or anxiety/depression scores.", "population_specificity": "50 patients with IBS symptoms complying with Rome III criteria, including subtypes (constipation-predominant, diarrhea-predominant, mixed, unsubtyped).", "effective_dosage": "Minimum daily dose of 6 \u00d7 10^8 colony forming units.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:45.904731+00:00"}
{"study_id": 72099, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the presence and effect of orally administered Lactobacillus casei rhamnosus (LCR35) in the vagina and its impact on Nugent scores in healthy women of child-bearing age.", "results_summary": "The mean Nugent score decreased in both dosage groups, with a higher proportion of women in the higher dosage group (40%) carrying LCR35 at the end of the trial. The study concluded that LCR35 at 2 \u00d7 10^8 CFU/day could normalize Nugent scores via temporary vaginal presence.", "population_specificity": "20 healthy women of child-bearing age.", "effective_dosage": "10^8 CFU/day (group 1) or 2 \u00d7 10^8 CFU/day (group 2).", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:46.353177+00:00"}
{"study_id": 72101, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to assess the effectiveness of a multispecies probiotic, including Lactobacillus Casei, in preventing necrotising enterocolitis (NEC) in preterm newborns weighing <1500 g.", "results_summary": "The study observed a trend toward reduced NEC frequency in the probiotic group (8% vs. 16% in controls) but no statistically significant NEC risk reduction. However, a post hoc analysis showed a significantly lower combined risk of NEC or death in the probiotic group.", "population_specificity": "Preterm newborns weighing <1500 g.", "effective_dosage": "1 g per day of a multispecies probiotic (containing Lactobacillus Casei among others).", "study_duration": "January 2007 through June 2010 (approximately 3.5 years).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:47.437396+00:00"}
{"study_id": 72102, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Lactobacillus casei Shirota (LcS) could reduce respiratory symptoms and improve immune response to influenza vaccination in elderly nursing home residents.", "results_summary": "The study found no statistically or clinically significant effect of LcS on respiratory symptom protection or influenza vaccination immune response. Both univariate and multivariate analyses showed no benefit from the probiotic intervention.", "population_specificity": "Elderly nursing home residents aged \u2265 65 years in Antwerp, Belgium.", "effective_dosage": "2 bottles of fermented milk daily, each containing \u2265 6.5 \u00d7 10^9 live LcS.", "study_duration": "176 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:47.439847+00:00"}
{"study_id": 72105, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate bacterial contamination, including Lactobacillus casei, on metallic orthodontic brackets after 30 days of use.", "results_summary": "Lactobacillus casei was detected in lower numbers compared to other cariogenic microorganisms like Streptococcus mutans and Streptococcus sobrinus (P <0.001). The study did not focus on its efficacy or safety but noted its presence among colonizing bacteria.", "population_specificity": "18 patients aged 11-29 years undergoing fixed orthodontic treatment.", "effective_dosage": "Not available", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:50.188831+00:00"}
{"study_id": 72103, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lactobacillus casei, combined with Bifidobacterium breve, could effectively treat antibiotic-associated diarrhea (AAD) in hospitalized patients.", "results_summary": "The study found no significant difference in treatment duration, cure rates, or relapse rates between the probiotic and placebo groups, concluding that L. casei and B. breve had no effect on AAD at the administered dosage. Adverse events like bloating, abdominal cramps, and vomiting occurred equally in both groups.", "population_specificity": "Hospitalized patients who developed diarrhea during or within 7 days of stopping antibiotic treatment.", "effective_dosage": "Three times a day (specific dosage not provided).", "study_duration": "Average treatment duration was approximately 5 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:50.542252+00:00"}
{"study_id": 72104, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of IL-1\u03b2 and caspase-1 in coronary arteritis induced by Lactobacillus casei cell wall extract (LCWE) in a murine model of Kawasaki disease.", "results_summary": "The study found that LCWE-induced IL-1\u03b2 maturation and secretion depended on the NLRP3 inflammasome in macrophages, and both caspase-1-deficient and IL-1 receptor-deficient mice were protected from LCWE-induced coronary lesions. IL-1 receptor antagonist prevented LCWE-mediated coronary lesions, suggesting anti-IL-1\u03b2 treatment as a potential therapy for Kawasaki disease.", "population_specificity": "Murine (mouse) model of Kawasaki disease", "effective_dosage": "Not specified", "study_duration": "Up to 3 days after LCWE injection", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:50.717792+00:00"}
{"study_id": 72106, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of Lactobacillus casei in preventing and treating diarrheal diseases, particularly antibiotic-associated diarrhea, in pediatric and adult populations.", "results_summary": "Lactobacillus casei was among the probiotics showing clear evidence of efficacy in preventing antibiotic-associated diarrhea, though it was less prominently effective compared to Lactobacillus GG and S. boulardii. The effect was noted to be strain-dependent and dose-dependent.", "population_specificity": "Pediatric and adult populations, including underprivileged areas and hospitalized children.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:51.502450+00:00"}
{"study_id": 72108, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate historical methods for measuring folate status, including the use of Lactobacillus casei assays, and compare them with newer techniques.", "results_summary": "The study found that Lactobacillus casei assays have been historically used to establish folate sufficiency ranges and dietary reference intakes, but newer protein binding assays and mass spectrometry methods are now being adopted despite variations in results.", "population_specificity": "Not specified (focus on methodological comparison rather than a specific human population).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:53.916702+00:00"}
{"study_id": 72110, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether Lactobacillus casei could prevent or treat small bowel injuries caused by chronic low-dose aspirin use.", "results_summary": "The study found that Lactobacillus casei significantly reduced the number of mucosal breaks and improved capsule endoscopy scores compared to the control group, indicating effectiveness in treating aspirin-associated small bowel injury.", "population_specificity": "35 patients taking low-dose aspirin and omeprazole with unexplained iron deficiency anemia.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:54.613048+00:00"}
{"study_id": 72107, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the contamination of metallic brackets by Lactobacillus Casei and the efficacy of 0.12% chlorhexidine gluconate mouthwashes in reducing bacterial contamination.", "results_summary": "Lactobacillus Casei was detected in 100% of the samples from both the control and experimental groups. While all bacterial counts decreased after rinsing with chlorhexidine, the reduction for Lactobacillus Casei was not statistically significant.", "population_specificity": "39 patients aged 11-33 years under treatment with fixed orthodontic appliances.", "effective_dosage": "0.12% chlorhexidine gluconate mouthwash used twice a week.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:55.032823+00:00"}
{"study_id": 72109, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of milk fermented with Lactobacillus casei Shirota on constipation in Parkinson's disease patients.", "results_summary": "The study found that probiotic intake significantly improved stool consistency and reduced bloating, abdominal pain, and sensation of incomplete emptying in Parkinson's disease patients with constipation.", "population_specificity": "Forty Parkinson's disease patients suffering from constipation according to Rome III criteria.", "effective_dosage": "65 mL fermented milk drink containing 6.5\u00d710^9 CFU of Lactobacillus casei Shirota daily.", "study_duration": "5 weeks (following a 1-week baseline period with dietetic therapy alone).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:56.458113+00:00"}
{"study_id": 72113, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of HealOzone on Lactobacillus casei in a tooth cavity model over 4 and 8 weeks.", "results_summary": "The study found no significant difference in the amount of Lactobacillus casei between the ozone-treated and control groups, indicating that L. casei was more resistant to ozone compared to Streptococcus mutans.", "population_specificity": "Caries-free third molars (n=12)", "effective_dosage": "Ozone treatment for 60 seconds", "study_duration": "4 and 8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:57.725756+00:00"}
{"study_id": 72112, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Lactobacillus casei Shirota (LcS) supplementation could reduce the incidence of upper respiratory-tract infections (URTIs) and influence immune markers in endurance-trained individuals during winter training.", "results_summary": "The study found that LcS supplementation significantly reduced the frequency of URTIs and maintained higher saliva IgA levels compared to placebo, though symptom severity and duration were unaffected.", "population_specificity": "Highly active men and women engaged in endurance-based physical activities.", "effective_dosage": "Daily (specific dosage not mentioned in the abstract).", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:58.457015+00:00"}
{"study_id": 72111, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplementation with Lactobacillus casei Shirota (LcS) could enhance NK cell activity in healthy men with reduced NK cell lytic function.", "results_summary": "The study found that 4 weeks of LcS supplementation had no significant effect on NK cell numbers, function, or other immune parameters like phagocytosis, respiratory burst, or cytokine secretion.", "population_specificity": "Healthy men preselected for reduced NK cell lytic activity (n = 68).", "effective_dosage": "1.95 \u00d7 10^10 CFU LcS per day.", "study_duration": "4 weeks of supplementation, preceded by a 2-week run-in and followed by a 2-week follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:22:59.233490+00:00"}
{"study_id": 72114, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether fermented milk containing Lactobacillus casei strain Shirota (LcS) could reduce hard or lumpy stools in healthy individuals with mild constipation.", "results_summary": "The study found that daily consumption of LcS-fermented milk significantly reduced the proportion of hard or lumpy stools (from 73.7% to 36.8%) and improved Bristol Stool Form Scale scores compared to the control group. The effects were statistically significant (P = 0.002 for H-HLS, P < 0.001 for BS score).", "population_specificity": "Healthy subjects with mild constipation (Bristol Stool Form Scale score < 3.0).", "effective_dosage": "Not specified (fermented milk containing LcS, daily).", "study_duration": "3 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:00.706817+00:00"}
{"study_id": 72115, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the immunogenic potential and inflammatory cytokine induction of Lactobacillus casei (DN-114 001) with other probiotic strains in human and mouse immune cells.", "results_summary": "Lactobacillus casei induced higher levels of the proinflammatory cytokine IFN-\u03b3 compared to Bifidobacterium breve but lower than Lactobacillus rhamnosus. The cytokine induction was TLR9-dependent, with no apparent role for TLR4, NOD2, or C-type lectin receptors.", "population_specificity": "Human and mouse primary immune cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:02.062487+00:00"}
{"study_id": 72117, "supplement_id": 1274, "safety_score": "75", "efficacy_score": 40, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether yogurt containing Lactobacillus casei, as part of a probiotic blend, improved H. pylori eradication rates or reduced adverse events when added to second-line triple therapy.", "results_summary": "The study found no significant improvement in H. pylori eradication rates or reduction in adverse events when probiotic yogurt was added to the treatment regimen. The eradication rates and adverse event rates were statistically similar between the yogurt and control groups.", "population_specificity": "337 patients with persistent H. pylori infection after first-line triple therapy.", "effective_dosage": "Not specified for Lactobacillus casei individually; yogurt contained a blend of probiotics (Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium longum, and Streptococcus thermophilus).", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:03.910254+00:00"}
{"study_id": 72116, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether short-term daily intake of milk supplemented with Lactobacillus rhamnosus LB21 affects the microbial profiles or levels of caries-associated bacteria in saliva and supragingival plaque of caries-active adolescents.", "results_summary": "The study found no statistically significant differences in microbial profiles or levels of caries-associated bacteria between the probiotic and placebo groups after the intervention. Lactobacillus casei was frequently identified in saliva samples but its levels were not significantly altered by the probiotic intervention.", "population_specificity": "18 caries-active adolescents of both sexes.", "effective_dosage": "2.5 dl of milk supplemented with Lactobacillus rhamnosus LB21 (10^7 CFU/ml) once daily.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:04.271056+00:00"}
{"study_id": 72118, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the immunomodulatory properties of Lactobacillus casei Shirota in birch-pollen-allergic subjects, focusing on its ability to reduce IL-13 levels.", "results_summary": "L. casei Shirota reduced the number of CD16(+)/CD56(+) cells in peripheral blood mononuclear cells but did not show significant changes in IgE or other immune markers like IL-5 and IL-13, unlike some L. plantarum strains.", "population_specificity": "62 subjects with a proven birch-pollen allergy.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:04.284778+00:00"}
{"study_id": 72119, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy of probiotic formulations, including Lactobacillus casei, in preventing Clostridium difficile infection.", "results_summary": "Only one study involving Lactobacillus casei and L. bulgaricus showed efficacy in preventing C. difficile infection, while other probiotic/prebiotic formulations did not demonstrate clinical benefit.", "population_specificity": "Patients at risk of or being treated for C. difficile infection.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:04.838543+00:00"}
{"study_id": 72120, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine whether combining Lactobacillus casei and Bifidobacterium breve could prevent necrotizing enterocolitis (NEC) stage \u2265 2 in very-low-birth-weight preterm infants.", "results_summary": "The study found that NEC stage \u2265 2 occurred only in the control group (4 cases), suggesting that the probiotic combination significantly reduced NEC incidence. The improvement was attributed to enhanced intestinal motility.", "population_specificity": "Very-low-birth-weight preterm infants (750\u20131499 g at birth).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:06.278470+00:00"}
{"study_id": 72121, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Lactobacillus casei DG on colonic microbiota, mucosal cytokine balance, and toll-like receptor expression in patients with mild left-sided ulcerative colitis.", "results_summary": "Rectal administration of L. casei DG, combined with 5-ASA, modified colonic microbiota by increasing Lactobacillus spp. and reducing Enterobacteriaceae, reduced TLR-4 and IL-1\u03b2 mRNA levels, and increased mucosal IL-10. Oral administration of L. casei DG with 5-ASA did not significantly affect colonic flora or TLR expression.", "population_specificity": "26 patients with mild left-sided ulcerative colitis.", "effective_dosage": "Not specified (oral and rectal administration, but exact dosage not detailed).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:08.372414+00:00"}
{"study_id": 72122, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether perioperative synbiotic therapy (including Lactobacillus casei) reduces infectious complications in patients undergoing elective living-donor liver transplantation.", "results_summary": "The study found that synbiotic therapy significantly reduced postoperative infectious complications (4% in the treatment group vs. 24% in the control group), with no difference in other complications.", "population_specificity": "Adult patients undergoing elective living-donor liver transplantation.", "effective_dosage": "Not specified (synbiotic therapy included Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides).", "study_duration": "2 days preoperative and 2 weeks postoperative.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:09.073889+00:00"}
{"study_id": 72123, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anticaries activity of a nanoemulsion containing cetylpyridinium chloride, using a biofilm model with Streptococcus mutans and Lactobacillus casei to simulate dental caries formation.", "results_summary": "The nanoemulsion significantly reduced lesion depth and mineral loss compared to both the control (no treatment) and chlorhexidine groups, demonstrating superior anticaries efficacy. Lactobacillus casei was part of the biofilm model but its direct effects were not separately analyzed.", "population_specificity": "Human tooth enamel blocks in an artificial mouth model.", "effective_dosage": "Nanoemulsion applied once daily for 30 seconds.", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:10.847393+00:00"}
{"study_id": 72127, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of Lactobacillus Casei as a probiotic, focusing on its immunomodulatory effects and potential use in vaccine development.", "results_summary": "The study highlights that Lactobacillus Casei, as part of lactic acid bacteria, plays a significant role in improving digestion, nutrient absorption, and immune response, with potential applications in oral vaccine development.", "population_specificity": "General animal and human populations (not specified in detail).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:12.553104+00:00"}
{"study_id": 72124, "supplement_id": 1274, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effects of a fermented milk beverage containing Lactobacillus casei strain Shirota (LcS) on defecation frequency, intestinal microbiota, and the intestinal environment in healthy individuals with soft stools.", "results_summary": "The study found that the probiotic significantly improved stool quality (hardened), reduced defecation frequency, and increased bifidobacteria levels in stools. Live LcS was recovered in stools, and organic acid levels increased during the intake period but returned to baseline afterward.", "population_specificity": "Healthy adults with soft stools.", "effective_dosage": "40 billion bacterial cells per bottle, 1 bottle/day.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:13.319609+00:00"}
{"study_id": 72125, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop and validate a selective medium (M-RTLV agar) to distinguish Lactobacillus casei from related species and confirm its ability to detect ingested L. casei in human feces.", "results_summary": "The M-RTLV agar successfully distinguished L. casei/L. paracasei from L. rhamnosus based on colony color. The study confirmed the detection of ingested L. casei strain Shirota (LcS) in fecal samples, with viable counts of approximately 6.5-6.6 log(10) CFU/g feces after daily consumption of Yakult or Yakult Light.", "population_specificity": "Human subjects consuming Yakult or Yakult Light.", "effective_dosage": "One bottle daily (containing L. casei strain Shirota).", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:14.110663+00:00"}
{"study_id": 72126, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the efficacy and safety of a probiotic blend containing Lactobacillus casei in reducing the incidence and duration of antibiotic-associated diarrhea (AAD) and Clostridium difficile-associated diarrhea (CDAD) in hospitalized patients.", "results_summary": "The study found that the probiotic blend significantly reduced the incidence and duration of AAD and CDAD compared to placebo, with higher doses (100 billion c.f.u.) showing superior outcomes and fewer gastrointestinal symptoms than lower doses (50 billion c.f.u.).", "population_specificity": "Adult inpatients on antibiotics.", "effective_dosage": "50 billion c.f.u. (one capsule) or 100 billion c.f.u. (two capsules) per day.", "study_duration": "Probiotic administration began within 36 hours of antibiotic initiation and continued for 5 days after the last antibiotic dose, with a 21-day follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:14.365602+00:00"}
{"study_id": 72128, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of probiotic supplementation, including Lactobacillus Casei, for treating constipation in adults and children.", "results_summary": "In adults, Lactobacillus casei Shirota showed a favorable effect on defecation frequency and stool consistency. In children, L. casei rhamnosus Lcr35 demonstrated a beneficial effect, while L. rhamnosus GG did not.", "population_specificity": "Adults and children with constipation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:14.883741+00:00"}
{"study_id": 201108, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of Lactobacillus casei on lipid metabolism and intestinal microflora in patients with alcoholic liver injury.", "results_summary": "The study found that high-dose Lactobacillus casei significantly reduced serum TG and LDLC levels and increased beneficial gut bacteria (Lactobacillus and Bifidobacterium) compared to the control group.", "population_specificity": "Patients with alcoholic liver injury (n=158) and a healthy control group (n=20).", "effective_dosage": "Low-dose (100 ml/day) and high-dose (200 ml/day) of Lactobacillus casei strain Shirota (LcS).", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:16.697145+00:00"}
{"study_id": 201111, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Lactobacillus casei Shirota (LcS) on gut microbiota composition, gut barrier integrity, intestinal inflammation, and serum bile acid profile in individuals with metabolic syndrome.", "results_summary": "LcS supplementation led to subtle microbiota changes at the genus level (enrichment of Parabacteroides) but did not significantly influence the Bacteroidetes/Firmicutes ratio, gut barrier dysfunction (zonulin and calprotectin levels), or serum bile acid profiles in metabolic syndrome patients.", "population_specificity": "28 subjects with metabolic syndrome (13 received LcS, 15 controls), compared to 16 healthy controls.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:19.966529+00:00"}
{"study_id": 201112, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine if high-dose Lactobacillus casei supplementation for 7 days enhances salivary antimicrobial protein responses to exertional-heat stress.", "results_summary": "The study found no significant changes in resting salivary antimicrobial protein responses with probiotic supplementation compared to placebo. While some increases in specific salivary markers occurred after exertional-heat stress, the probiotic did not provide additional immune protection over placebo.", "population_specificity": "Eight endurance-trained male volunteers (age 26 \u00b1 6 years).", "effective_dosage": "10^11 colony-forming units per day.", "study_duration": "7 consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:21.016438+00:00"}
{"study_id": 21836, "supplement_id": 1275, "safety_score": "30", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of Lactobacillus reuteri in exacerbating CPT11-induced intestinal mucositis by examining its impact on gut microbiota and intestinal stem cell differentiation.", "results_summary": "The study found that Lactobacillus reuteri, a GUS-expressing bacterium, worsened CPT11-induced mucositis by impairing intestinal stem cell differentiation and epithelial regeneration, while its elimination alleviated symptoms and preserved stem cell function.", "population_specificity": "CPT11-treated mice and clinical patients with mucositis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "CPT11 (chemotherapy drug)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:22.238203+00:00"}
{"study_id": 201113, "supplement_id": 1274, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how Lactobacillus casei subsp. Rhamnosus (LGG) supplementation affects infant gut microbiota composition and its potential role in preventing allergic diseases.", "results_summary": "Infants with high LGG abundance showed promotion of phylogenetically clustered probiotic species and more even microbial distribution, characteristics linked to resistance against pathogens and reduced atopy-associated taxa. The findings suggest LGG may protect against allergic disease by fostering a stable, balanced gut community.", "population_specificity": "6-month-old infants", "effective_dosage": "Daily supplements (specific dosage not mentioned)", "study_duration": "Not specified (follow-up at 6 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:22.741801+00:00"}
{"study_id": 21837, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the immunomodulating effects of Tyndallized (heat-killed) Lactobacillus reuteri postbiotics on canine peripheral blood mononuclear cells (PBMCs) to assess their potential for managing atopic dermatitis.", "results_summary": "The study found that Tyndallized Lactobacillus reuteri significantly increased levels of Th1 cytokines (IL-12, IFN-\u03b3) and IL-10 (associated with T regulatory cells), while Th2 cytokine (IL-4) levels remained stable, suggesting an anti-allergic immune response.", "population_specificity": "Healthy dogs", "effective_dosage": "Not specified", "study_duration": "PBMCs were incubated for up to 72 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:22.858877+00:00"}
{"study_id": 21838, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the in vitro inhibitory effects of Lactobacillus reuteri strain I300 against H. pylori, focusing on adhesion, invasion, and inflammation modulation.", "results_summary": "L. reuteri I300 and its formulations significantly reduced H. pylori adhesion and invasion of AGS cells, decreased proinflammatory cytokines (TNF-\u03b1, IL-8), increased anti-inflammatory cytokine (IL-10), and upregulated E-cadherin expression to promote epithelial cell integrity.", "population_specificity": "In vitro study using AGS cells (human gastric adenocarcinoma cell line) and H. pylori.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:23.911233+00:00"}
{"study_id": 201110, "supplement_id": 1274, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine if short-term high-dose probiotic supplementation with Lactobacillus casei could reduce exertional-heat stress-induced endotoxinaemia and cytokinaemia.", "results_summary": "The study found that L.casei supplementation did not significantly attenuate endotoxinaemia or cytokinaemia compared to placebo, with only minor trends in higher endotoxin and TNF-\u03b1 levels post-exercise.", "population_specificity": "Eight endurance-trained male volunteers (age 26 \u00b1 6 years, VO2max 59 \u00b1 5 ml\u00b7kg-1\u00b7min-1).", "effective_dosage": "Volume equivalent to 10^11 colony forming units per day.", "study_duration": "7 consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:24.468917+00:00"}
{"study_id": 21839, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Lactobacillus reuteri NCHBL-005 enhances fibroblast-mediated wound healing through TLR2 stimulation and MAPK pathway activation.", "results_summary": "L. reuteri NCHBL-005 significantly accelerated wound closure in fibroblasts, activated the MAPK pathway, and promoted fibroblast proliferation and differentiation, with TLR2 being critical for this mechanism. In vivo studies confirmed enhanced wound healing and fibroblast activation.", "population_specificity": "L929 fibroblast cells, mouse embryonic fibroblasts (MEFs), and wound models in mice (including TLR2-/- mice).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:26.226301+00:00"}
{"study_id": 21841, "supplement_id": 1275, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "To assess the efficacy of Lactobacillus reuteri DSM 17938 as an adjunct to oral rehydration therapy in treating acute gastroenteritis in children.", "results_summary": "L. reuteri reduced the duration of diarrhea and frequency of watery stools compared to placebo, with significant differences observed by day 5 of treatment. The intervention was deemed safe and effective in emergency management.", "population_specificity": "Children aged 1 to 60 months with acute gastroenteritis and mild to moderate dehydration.", "effective_dosage": "Not specified", "study_duration": "Up to 5 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:28.051868+00:00"}
{"study_id": 21842, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the clinical and microbiological efficacy of locally administered biodegradable fibers containing Lactobacillus reuteri as an adjunct to scaling and root planing (SRP) in managing chronic periodontitis.", "results_summary": "The test group showed significant improvements in clinical parameters (45.66% reduction in plaque index, 57.83% reduction in bleeding index, and 43.06% improvements in probing pocket depth and clinical attachment level) and a 63.00% reduction in microbial load compared to the control group.", "population_specificity": "30 patients aged 30-60 years diagnosed with chronic periodontitis.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:29.303460+00:00"}
{"study_id": 21844, "supplement_id": 1275, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to summarize the role of Lactobacillus reuteri in oral and systemic health and explore its potential applications in preventing and treating oral diseases.", "results_summary": "Lactobacillus reuteri shows promise in treating biofilm-dependent oral diseases and may benefit overall health, but its mechanisms and efficacy require further research.", "population_specificity": "Not specified (general human microbiota context).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:29.611131+00:00"}
{"study_id": 21843, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Lactobacillus reuteri on growth performance, intestinal immunity, and intestinal barrier integrity in weaned piglets.", "results_summary": "L. reuteri did not significantly affect growth performance but improved intestinal health by reducing liver enzyme levels, enhancing immunoglobulin concentrations, improving gut barrier function, and modulating inflammatory cytokine expression.", "population_specificity": "Weaned piglets of similar age and weight.", "effective_dosage": "Not specified.", "study_duration": "16 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:29.798912+00:00"}
{"study_id": 21846, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lactobacillus reuteri ZJ617 supplementation could ameliorate metabolic syndrome symptoms in mice and explore its mechanism of action.", "results_summary": "L. reuteri ZJ617 improved metabolic syndrome symptoms in high-fat diet-induced mice by modulating host metabolism and microbiome interactions, leading to increased spermidine production. Spermidine treatment replicated these benefits, while its inhibition negated them.", "population_specificity": "High-fat diet-induced metabolic syndrome mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:31.599460+00:00"}
{"study_id": 21845, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of dietary supplementation with Lactobacillus reuteri postbiotics on growth performance, intestinal flora structure, and plasma metabolome in weaned piglets.", "results_summary": "The study found that Lactobacillus reuteri postbiotics reduced piglet mortality by 6.37%, improved antioxidant function (increased superoxide dismutase, decreased malondialdehyde), and modulated intestinal flora (increased Firmicutes, decreased Bacteroides). It also elevated fecal propionic and butyric acid levels and serum coenzyme Q10.", "population_specificity": "Weaned male piglets with uniform weight.", "effective_dosage": "500 mg/kg of diet.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:32.022647+00:00"}
{"study_id": 21847, "supplement_id": 1275, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether Lactobacillus reuteri (LR) could alleviate intestinal inflammation caused by immunotherapy without compromising the antitumor efficacy of the engineered strain REP.", "results_summary": "LR modulated inflammatory markers (IL-1\u03b2, IL-6, IL-10) via the JNK pathway, reducing intestinal inflammation while maintaining REP's antitumor effects. The combination showed no detectable systemic toxicity beyond mild intestinal damage.", "population_specificity": "Breast cancer model (likely murine, based on context).", "effective_dosage": "Not specified for LR alone (REP dosage was 10^8 CFU).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:32.291805+00:00"}
{"study_id": 21848, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether L. reuteri could alleviate hyperoxia-induced lung injuries in mice and whether its effects were mediated via the IL-22/STAT3 pathway.", "results_summary": "L. reuteri and its metabolite 3-IAld reduced lung injury, decreased proinflammatory cytokines, and increased protective proteins (SPC, AQP5, VEGFR2). The protective effects were linked to IL-22 production and STAT3 activation.", "population_specificity": "Preterm infant model (hyperoxia-induced lung injury in mice)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:34.406872+00:00"}
{"study_id": 21849, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to elucidate the mechanisms by which Lactobacillus reuteri improves intestinal barrier function and glucose homeostasis, particularly through its metabolite eicosatrienoic acid (ETA).", "results_summary": "The study found that L. reuteri gavage increased ETA levels, which promoted GLP-1 secretion via CD36-activated signaling, enhancing intestinal barrier integrity and improving glucose homeostasis in high-fat diet (HFD) and db/db mice. These effects were mediated through the PI3K/AKT/HIF-1\u03b1 pathway, reducing inflammation and serum LPS levels.", "population_specificity": "HFD-fed mice and db/db mice (a model for type 2 diabetes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:37.173347+00:00"}
{"study_id": 21852, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of L. reuteri LY2-2 in alleviating colitis in mice and explore its underlying mechanisms.", "results_summary": "L. reuteri LY2-2 significantly reduced colitis severity by lowering pro-inflammatory cytokines, inhibiting TLR4-NF-\u03baB signaling, restoring immune balance, and improving gut barrier function. It also modulated macrophage polarization and improved gut microbiota composition, outperforming the 5-ASA drug control.", "population_specificity": "Mice with DSS-induced colitis", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:37.357882+00:00"}
{"study_id": 21851, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of Lactobacillus reuteri TISTR 2736 on glucose homeostasis, carbohydrate metabolism, and related mechanisms in type 2 diabetic rats.", "results_summary": "L. reuteri TISTR 2736 improved fasting blood glucose, glucose intolerance, insulin sensitivity, hepatic histopathology, and reduced oxidative stress and inflammation in diabetic rats by modulating the IRS1/PI3K/AKT pathway.", "population_specificity": "Type 2 diabetic rats induced by a high-fat diet and streptozotocin.", "effective_dosage": "2 \u00d7 10^8 CFU/day", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:37.393052+00:00"}
{"study_id": 21850, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Lactobacillus reuteri and LGG on social behavior, gut health, and oxidative stress in a rat model of autism spectrum disorder (ASD) induced by prenatal LPS exposure.", "results_summary": "Lactobacillus reuteri improved social deficits, reduced anxiety, enhanced colonic barrier integrity, modified short-chain fatty acid profiles, and mitigated oxidative stress and inflammation in LPS-exposed rats and Caco-2 cells.", "population_specificity": "Offspring of LPS-exposed pregnant rats (ASD model) and H2O2-induced oxidative stress in Caco-2 cells.", "effective_dosage": "Not specified", "study_duration": "Three weeks post-birth (rats)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:37.696215+00:00"}
{"study_id": 21853, "supplement_id": 1275, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the cancer therapeutic efficacy of extracellular vesicles derived from Lactobacillus reuteri (REVs) when administered orally, both independently and in combination with other therapies.", "results_summary": "REVs demonstrated stability in the gastrointestinal tract and significant anti-tumor effects by modulating apoptotic signaling pathways in A549 cells and murine models. Combining REVs with drugs enhanced tumor ablation and induced immunogenic cell death, with complete tumor elimination observed in a mouse model after 32 days of oral REV administration combined with photothermal therapy.", "population_specificity": "A549 cells and murine models (mice)", "effective_dosage": "Not specified", "study_duration": "32 days", "interactions": "Enhanced tumor ablation when combined with drugs and photothermal therapy", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:23:40.358958+00:00"}
